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ABSTRACT OF DISSERTATION

THE ROLE OF CD8 T CELL IMMUNODOMINANCE AND REGULATORY T
CELLS IN NEONATAL IMMUNITY TO INFLUENZA VIRUS
Neonates are more susceptible to influenza virus infection than adults, resulting in
increased morbidity and mortality as well as delayed clearance of the virus. Efforts to
improve influenza infection outcomes in neonates typically center on prevention,
although current vaccines fall short of complete protection and can only be administered
in humans after 6 months of life. We propose that as the neonatal immune system
responds differently than the adult immune system, interventions that are efficacious or
tolerable in adults cannot be guaranteed to perform the same in neonates. T cell vaccines
that target conserved influenza virus epitopes have been proposed for conferring
protection to multiple influenza virus strains, but if T cell vaccines will be used in infants
and adults, neonates must be able to respond to the same T cell antigens as adults. Mouse
pups responded to influenza virus peptide PA224-233 but not NP366-374 during influenza
virus infection in contrast to the codominant adult response. Mice infected as pups also
generated diminished T cell memory compared to mice infected as adults and displayed
skewed immunodominance during secondary infection. Adult bone marrow derived
dendritic cells (BMDCs) improved viral clearance when loaded with influenza virus and
promoted NP366-374-specific CD8+ T cell responses in infected pups. BMDC peptide
vaccination could stimulate PA224-233-specific but not NP366-374-specific CD8+ T cell
responses in pups, but, PA224-233 vaccination offered no protection to pups during lethal
infection. These data suggest that altered immunodominance must be considered when
stimulating CD8+ T cell responses in adults and neonates.
Immaturity and active suppression of immune responses are both factors in
neonatal vulnerability to disease. Specifically, active suppression of neonatal immunity
by regulatory T cells (Tregs) has been proposed as a driving factor in diminished neonatal
immunity, but removing these cells can compromise viral defense or increase deleterious
inflammation. Mice that lacked Tregs displayed compromised anti-influenza antibody
responses and decreased lymph node responses during influenza virus infection. A high
proportion of pup Tregs also expressed Gata3. Transgenic pups with a Treg specific
Gata3 knockout displayed an increase in Tbet expression in both conventional and
regulatory T cells and an increase in IFNγ producing CD4+ T cells in the lungs during
infection. These data suggest that Tregs are required for effective humoral responses to
influenza virus and that Gata3 expression influences Treg suppressive function in
neonates.
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CHAPTER 1. OVERALL INTRODUCTION
1.1

Introduction
Influenza virus is a single stranded enveloped orthomyxovirus responsible for

mild to severe recurrent, seasonal respiratory disease in humans worldwide (Cottey et al.,
2001; Oshansky et al., 2012). Disease burden varies year to year, but the CDC estimates
that influenza infections were responsible, in the United States, for 9.3- 49 million
symptomatic illnesses, 140,000- 960,000 hospitalizations and 12,000- 79,000 deaths each
year since 2010. This significant burden remains despite vaccination efforts (Antonova
et al., 2012; Nelson et al., 2014; Reed et al., 2015). The elderly and the young are
particularly impacted due to less robust vaccine responses and less effective anti-viral
immune responses, and special effort must be dedicated to protecting these populations
(Neuzil et al., 2002).
Both vaccines and natural infections fail to induce long-lasting protective
immunity to influenza virus due to the virus’s high mutation rate and host responses that
preferentially target epitopes of the virus that are prone to mutation (Sridhar et al., 2015;
Thommes et al., 2017). Seasonal influenza vaccines offer some protection by predicting
the common Influenza A and B strains that will be prevalent in a specific year and
generating antibody responses against those viruses (Grohskopf et al., 2018). Vaccine
effectiveness hovers around roughly 40-60% effectiveness each year, but some seasons
have much poorer results such as the 2014-15 season (19%) (Jackson et al., 2017) and the
2004-05 season (10%) (Belongia et al., 2009).
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Multiple efforts are underway to address the limitations of current influenza
vaccination strategies, such as using subunit T cell antigens or broadly neutralizing
antibodies to generate memory that is not susceptible to influenza virus’s usual rapid
immune evasion (Estrada et al., 2019). Both of these strategies attempt to bypass the
limitations of reactions generated by natural infections and conventional vaccination
methods to protect against a wide range of influenza virus strains (Gottlieb et al., 2014;
Lee et al., 2019).
Influenza virus is the leading cause of hospitalizations and deaths for vaccine
preventable illnesses in children (Reed et al., 2015). Immune responses are different in
children than in adults, resulting in both decreased protection from natural infections as
well as diminished responses to vaccines (Basha et al., 2014). Children under six months
of age cannot be vaccinated against influenza virus, and children under five years of age
require two injections of the vaccines instead of the one adults and older children require
(Grohskopf et al., 2018). Any novel vaccination strategy must be evaluated in the
context of early life immune responses.
The purpose of this dissertation is to investigate neonatal responses to influenza
virus in two ways. First, to test the hypothesis that neonates must be vaccinated
differently than adults when considering T cell vaccines, and second, to test the
hypothesis that Tregs perform a vital anti-viral role in influenza virus clearance in
neonates.

2

1.2

Lung
Like all mucosal surfaces, the lung requires specialized immune functions to

protect the host from the consequences of exposing a region of the body to external
microorganisms without the barrier of skin to protect it. The respiratory tract is generally
divided into the upper and lower respiratory tracts with the upper tract comprising the
nose, nasal cavities, sinuses, pharynx, and the upper part of the larynx and the lower tract
comprising the lower larynx, trachea, bronchi, bronchioles and most importantly the
alveoli where gas exchange occurs (Hsia et al., 2016). Most contact with microorganisms
occurs in the upper respiratory tract, but bacteria can also be found in the lower alveoli
under normal conditions (Hilty et al., 2010).
The lungs contain colossal surface area and extensive vascularization to facilitate
gas exchange, and perturbations to the steady state conditions can easily cause damage or
blockages that could be devastating. Immune responses in the lungs must balance
potency with tolerance to avoid pathology, particularly in neonates as infants are still
undergoing lung development after birth and cannot afford to lose any of their already
limited respiratory capacity (Harbeson, Ben-Othman, et al., 2018; Harbeson, Francis, et
al., 2018; Lee et al., 2010). Additionally it is well recognized now that infections early in
life can have lasting consequences for lung function, particularly in the development of
asthma (Merkus, 2003). Early infections with Respiratory Syncytial Virus (RSV)
(Feldman et al., 2015) and human rhinovirus (HRV) (Miller et al., 2009) have been
closely linked to later development of asthma.

3

The immune system in the upper respiratory tract functions much like it does in
other mucosal surfaces, such as the gut, with extensive immunosurveillance by dendritic
cells and secretion of IgA. The conducting airways have an epithelial layer containing
some dendritic cells that extend processes into the airway to sample airborne antigens
(Geurts van Kessel et al., 2008; Neyt et al., 2013). The lamina propria contains other
immune cells such as macrophages, T cells and plasma cells that secrete IgA and
maintain surveillance for potential pathogens (Habibi et al., 2015; Lanka et al., 2016).
The alveoli have a few additional components due to the unique challenges and
needs of the environment. Alveolar macrophages live within the airspace and function
both as cleanup for debris that accumulates in alveolar spaces as well as sentinels for
infection (Hussell et al., 2014). The parenchyma surrounding the alveoli contains
dendritic cells, T cells and other immune cells that are poised to quickly intervene if a
pathogen is detected. During an infection, many cells will move into the alveolar spaces
including monocyte-derived macrophages, neutrophils and both CD4+ and CD8+ T cells
(Strickland et al., 1996). This appears to be important to clearance of many pathogens,
but an influx of cells and fluid often compromises local alveolar function until the
inflammation is resolved (Das et al., 2016; Lines et al., 2010).
The neonatal lung in humans and mice is immature at birth with thick walled
alveoli resembling buds from the ends of bronchioles. These proto-alveoli then expand
and thin to form mature adult alveoli (Hsia et al., 2016). In humans, alveolar
development occurs both before and after birth and is complete by around eight years of
life (Langston, 1983). In mice, most of this development occurs in the first two weeks of
life (Foster et al., 2006). This process is mediated by several growth factors including
4

constitutive expression of transforming growth factor beta (TGFβ). TGFβ is required for
proper lung development, but it also may play a role in establishing the
immunosuppressive environment of the neonatal lungs (Alejandre-Alcazar et al., 2008;
Nakanishi et al., 2007).
Neonates consistently demonstrate reduced immune function across a wide
variety of infections, although they can clear low doses of pathogens (Basha et al., 2014).
This observed deficiency has been theorized to be necessary to accommodate the delicate
demands of the neonatal lungs (Harbeson, Francis, et al., 2018; Medzhitov et al., 2012).
Early in life, the neonatal immune system must learn to tolerate the vast array of novel,
innocuous antigens that every human encounters in daily life without succumbing to
pathogens. This balance plays out in the unique functions of neonatal immunity,
although the cost is undeniable. Neonates are more susceptible to infections, and
although efforts are being made to improve outcomes for infected infants, care must be
taken to maintain the balance. Enhanced clearance does little good if extensive pathology
is the byproduct (Delgado et al., 2009).

1.3

Influenza virus
Influenza viruses comprise four of the seven genera of Orthomyxoviridae,

although most attention in human health is given to influenza A and B. Influenza A is the
subject of this study and the focus of this section. Influenza A is an enveloped, singlestranded RNA virus with a segmented genome. Influenza A has eight RNA gene
segments that encode ten to fourteen proteins depending on the strain (Nakatsu et al.,
2016). The most common list of these proteins includes the surface proteins
5

hemagglutinin (HA) and neuraminidase (NA), RNA polymerase subunits PB1, PB2 and
PA, the nucleoprotein NP, the matrix proteins M1 and M2, two non-structural proteins
NS1 and NEP, and an apoptosis inducing protein PB1-F2 (Edinger et al., 2014).
Influenza viruses are classified by their HA and NA serotype. H1N1 and H3N2
are the influenza A types responsible for seasonal influenza infections (Grohskopf et al.,
2018). H5N1 and less commonly H7N9 are avian influenza strains that cause severe but
uncommon disease in humans (Brankston et al., 2007). Genetic drift occurs within these
serotypes so that one H1N1 strain is often not identical to another, but these broad
categorizations are helpful in delineating general groups of influenza viruses (Stellrecht
et al., 2017) (Figure 1.1).
Hemagglutinin is responsible for viral attachment, entry and uncoating. It has a
highly conserved stalk region called HA1 and a more globular head region called HA2
that binds to sialic acids on target cells (Krammer et al., 2019). This binding is highly
specific with human influenza virus strains binding to α(2,6) sialic acids and avian
viruses binding to α(2,3) sialic acids (Edinger et al., 2014). Pigs have both α(2,3) and
α(2,6) sialic acids allowing human and avian viruses to co-infect pig cells and to mix and
re-assort into dangerous new strains. α(2,6) sialic acids are primarily expressed on the
surface of ciliated epithelial cells of the upper respiratory tract in humans, and as a result,
almost all infected cells in humans are respiratory epithelial cells (Ibricevic et al., 2006).
Once the virus is endocytosed, the pH within the endosome drops causing a
conformational change in the HA protein that allows the viral membrane to fuse with the
endosome. The viral contents are then released into the host cytoplasm (Banerjee et al.,
2014; Edinger et al., 2014).
6

The viral gene segments each comprise a viral RNA surrounded by multiple NP
proteins and a polymerase complex of PA, PB1 and PB2 (Lakdawala et al., 2016). These
segments traffic to the host cell nucleus where viral replication begins (Oymans et al.,
2018). NS1 inhibits host cell protein production to conserve resources for viral
replication (Diebold et al., 2003). The ER processes HA, NA and M2 before they are
glycosylated in the golgi apparatus and move to the apical side of the cell membrane
(Edinger et al., 2014). There, new viruses are assembled and loaded with all eight gene
segments (Takizawa et al., 2016). Evidence suggests that this process is not random and
that the vast majority of assembled viruses contain the complete set of viral gene
segments (Nakatsu et al., 2016; Samji, 2009).
As influenza is an enveloped virus, complete virions bud from infected cells. The
HA on the virus’s surface binds to sialic acids on the host cell, which could prevent
spread of the virus to new cells, but NA cleaves the sialic acids and allows the virus to
escape. (Kosik et al., 2019) (Figure 1.2). Influenza viruses with neutralized NA
accumulate on the host cell membrane, preventing effective spread (Palese et al., 1974).

1.4

Influenza disease
Influenza is typically acquired through contact with infected materials from an

infected person. Respiratory secretions of infected humans contain large quantities of the
virus and this can be spread via airborne droplets or surfaces contaminated by droplets
(Brankston et al., 2007). These droplets are typically created by sneezing or coughing,
although there is evidence that simply breathing can spread them as well (Ortigoza et al.,
7

2018). The droplets must be breathed in to come in contact with the respiratory epithelial
cells required for viral infection of host tissues (Ibricevic et al., 2006).
The incubation period for influenza virus in humans is one to four days at which
point symptomatic disease manifests. Uncomplicated influenza begins with onset of
fever, myalgia, malaise and headache that persists for several days (Nicholson, 1992).
Viral shedding occurs before symptomatic disease and continues for an average of 6.4
days (Carrat et al., 2008; Lee et al., 2009). Degree of severity of symptoms correlates
with magnitude of viral shedding (Lau et al., 2010; Peteranderl et al., 2016). After
resolution of symptoms, some patients experience persistent fatigue and weakness
(Nicholson, 1992).
In mice, the disease course is very similar although there are recognized
differences in murine infections verses human infections (Bouvier et al., 2010; Thangavel
et al., 2014). (See mouse model of influenza, page 9). After intranasal inoculation with
A/Puerto Rico/8/1934 influenza virus (PR8), adult mice experience an infection that
peaks around day seven of infection before the virus is rapidly cleared by day 10 of
infection. Neonates experience a longer course with clearance around day 14 of infection
(Lines et al., 2010). Neither C57Bl/6 adults nor pups transmit the virus although a few
other mouse strains can transmit certain influenza viruses as pups (Ortigoza et al., 2018).
Morbidity is assessed by weight loss in adults which can be profound. Pups typically will
not lose any weight during infections, but they will stop gaining weight as an indication
of morbidity (Lines et al., 2010).
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1.5

Mouse model of influenza
Influenza virus infection in immunocompetent humans is an uncomplicated,

predominantly upper respiratory infection that may be transmitted between hosts for 8 to
9 days after infection (Brankston et al., 2007). Several animal systems exist to model this
infection including mice, ferrets, and non-human primates (Bouvier et al., 2010;
Thangavel et al., 2014). Ferrets and non-human primates most closely model the disease
course of humans as they primarily develop upper respiratory infections, may be infected
with human isolates of influenza virus without adaptation, and can transmit the virus
between hosts through coughing, but they are expensive to maintain and few reagents
exist for these species (Smith et al., 1933; Thangavel et al., 2014). Mice are not a natural
host for influenza, but they may be infected with mouse-adapted strains of influenza virus
(Thangavel et al., 2014). They develop lower respiratory infections and do not typically
transmit the virus to other mice (Ortigoza et al., 2018). For these reasons, mice are often
viewed as a poor model of influenza virus infection in humans, but the advantages of
mice as a model organism are widely recognized and may justify the use of mice in
answering many questions regarding immunity to influenza virus. Mice are readily
available, cheap, and easy to breed. Many reagents exist for use in the species and many
genetically modified mouse strains already exist. The use of mouse models has already
allowed for the discovery of much of the current knowledge of influenza virus infection:
knowledge that would have been much harder to discover in more challenging animal
models. I believe these considerations justify the use of mouse models in influenza
research, although care must be taken to interpret results in light of the limitations of this
artificial infection system.
9

The second consideration for the use of a mouse model in these studies is the
suitability of mice for studying neonatal immunology and infection. The lungs of mouse
and human infants differ in early life with humans undergoing significant alveolarization
in the third trimester while mice alveolize predominantly shortly before birth and through
the first two weeks of life (Alejandre-Alcazar et al., 2008; Langston, 1983).
Additionally, there are lymphocyte trafficking differences, with mice populating their
peripheral tissues with lymphocytes after birth, while humans typically do so during
gestation. This means that immune cell populations in the lung may look significantly
different between mice and humans until mice finish populating their lungs. Some
studies have suggested that a 7 day old mouse immune system resembles the immune
system of a human infant (Adkins, 2005).
Interestingly, mice may be a better model for neonatal influenza infection than for
adult influenza virus infection. While humans typically develop upper respiratory
infections when exposed to influenza virus, human infants can develop severe interstitial
pneumonia and lower respiratory infections (Guarner et al., 2006). In this way, the
interstitial pneumonia and lower respiratory infections displayed by neonatal mice match
human illness fairly well. Of course, the underlying reality is that influenza studies in
human infants are extremely challenging for ethical and practical reasons. Mice
represent a system to glean answers about neonatal immunobiology that would be
impossible to otherwise obtain. For this reason, mice are a reasonable model for studying
influenza virus infection in neonates.

10

1.6

Typical viral immunity in adults
The response to viral pathogens follows a general pattern in humans and mice.

Sterilizing viral immunity will be considered here, as influenza is not typically
considered a chronic infection. First, the virus is detected, and early innate immune
functions such as NK cells and type I interferons keep the virus from undergoing
unchecked replication before the adaptive immune system can reach full functionality
(Fensterl et al., 2015; Schoggins et al., 2011). Once adaptive immune cells are
differentiated and expanded, the virus is sterilized and the expanded populations of cells
contract until memory populations of T and B cells remain (Chen, Liu, et al., 2018).
Vaccination efforts are mainly interested in the adaptive immune response, especially
neutralizing antibody responses, but the entire process is worth considering when
evaluating an adult or neonatal immune response to a specific pathogen.
There are several methods for a host to detect a viral infection. These include
receptors such as Toll-like receptors (TLRs), nucleotide oligomerization and binding
domain (NOD)–like receptors (NLRs), C–type lectin receptors (CLRs), intracellular
retinoic acid inducible gene–I (RIG-I)-like receptors (RLRs), and the Pyrin and HIN
domain (PYHIN) receptors (Braciale et al., 2013). These receptors recognize pathogen
associated molecular patterns (PAMPs) such as viral nucleic acids or danger-associated
molecular patterns (DAMPs) such as ATP or other components released from
necrotic/apoptotic cells (Yoo et al., 2013). Once a PRR binds to a PAMP, signaling
cascades are activated leading to the production of cytokines.
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Type I interferons are critical mediators of innate immunity in the early stages of
viral defense. IFN-α and IFN-β are the major members of this group, although there are
other members (Schoggins et al., 2011). Type III interferons also play a role in viral
defense and include IFN-λ. These are much more recently described than type I
interferons and are structurally distinct from them, but they perform similar functions,
namely inhibition of viral replication (Durbin et al., 2013; Mordstein et al., 2008).
Animals that lack type I interferons are exquisitely sensitive to viral infections (Clay et
al., 2014). In fact, C57BL/6 mice lack MX1, a gene responsible for some of the
functional response to interferon signaling, and as a result, these mice, as well as may
other lab mouse strains that lack MX1, are more susceptible to influenza virus infection
than mice with an intact MX1 (Ciancanelli et al., 2016; Shin et al., 2015).
Dendritic cells are one of the bridges between innate and adaptive immunity, as
they are potent activators of T cells and assist in the activation of B cells as well as
detecting pathogens and producing cytokines (Neyt et al., 2013). Dendritic cells are not a
homogeneous population, but in general, they express a range of PRRs and are able to
phagocytose pathogens. This allows them to recognize pathogens and internalize them
for processing and presentation on MHC class I and MHC class II to T cells (Dinter et al.,
2014). After encountering a virus in the periphery, dendritic cells migrate to secondary
lymphoid organs such as lymph nodes to encounter naïve T and B cells (Geurts van
Kessel et al., 2008). They express high levels of co-stimulatory molecules like CD40 and
CD80/86, making them the most potent antigen presenting cells (APC) for stimulating T
cell responses to a viral infection (Larsson et al., 2000).
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Naïve pathogen-specific CD8+ and CD4+ T cells encounter dendritic cells and
other APCs in the secondary lymphoid tissue and become activated (Ho et al., 2011).
Activated T cells then migrate to the site of infection or remain in the lymphoid tissue to
help activate B cells and promote the production of high quality antibodies for viral
neutralization (Inoue et al., 2018; Nolz, 2015). In the infected tissue, CD4+ and CD8+ T
cell cytokine production helps recruit effector cells to the site of infection and CD8+ T
cell cytotoxicity kills virally infected cells, removing sites of viral replication (Chen, Liu,
et al., 2018). Although innate mechanisms may be able to protect against some viruses
or infectious doses, T cell activity is usually required for sterilizing immunity to a viral
pathogen (Epstein et al., 1998; Graham et al., 1991). In fact, many viruses downregulate
MHC class I in an attempt to evade CD8+ T cell recognition. The absence of MHC class
I helps activate natural killer cells which can then kill infected cells in a non-antigen
dependent manner (Mahmoud et al., 2016).
B cells are activated by antigens transported to the secondary lymphoid tissue and
begin to proliferate forming germinal centers with the help of T follicular helper cells
(Tfh) (Xu, Ziani, et al., 2018). During this time they undergo selection and can switch
antibody class in a process known as affinity maturation. The goal of this process is to
generate plasma cells that can create vast quantities of high-quality antibodies for viral
neutralization and clearance (Inoue et al., 2018).
After the pathogen is cleared, contraction of adaptive immune cell populations
occurs with some T and B cells differentiating into a memory phenotype. Long-lived
plasma cells may migrate to the bone marrow for maintenance. Some memory T cells
remain in the tissue, while others become circulating memory cells (Nguyen et al., 1999).
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1.6.1

General viral immunity in neonates
The neonatal immune response to viruses follows the same steps as the adult

response, but differences in both the timing and magnitude of the various components of
that response result in a general increase in susceptibility to infection, morbidity, and
mortality in this population.
TLR expression is similar between neonates and adults, but neonates display
much lower type I interferon production than adults after TLR stimulation (De Wit et al.,
2004), hampering initial viral defense. Neonates have dendritic cells that can take up
virus and present it to the adaptive immune system, but these cells are both less abundant
in the periphery and less active than their adult counterparts resulting in delays
throughout the reaction (Gold et al., 2007; Ruckwardt et al., 2014). Activation and
proliferation of T and B cells in the secondary lymphoid tissues happens later in neonates
resulting in delayed migration of adaptive immune cells to infected tissues (Lines et al.,
2010). Once there, neonatal T and B cells display reduced functionality including lower
antibody production, reduced cytotoxicity and reduced and skewed cytokine production
(Adkins et al., 1998; Fernandez et al., 2008b; Holbrook et al., 2015).
These factors all contribute to the overall outcomes of neonatal infections. Low
infectious doses of virus are not adequately controlled by low levels of type I interferon.
This allows virus to expand, leading to a serious infection more easily than in adults.
After this, the delayed T cell migration and diminished quality and quantity of anti-viral
antibodies allows further expansion of the virus and delays clearance, extending disease
course and contributing to morbidity and mortality (Basha et al., 2014).
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Much less work has been done characterizing neonatal immunity compared to the
extensive study of adult immunity. Studies with neonates are challenging to perform, and
as a result, basic information about neonatal responses to many pathogens is currently
lacking.
1.6.2

Respiratory syncytial virus and the study of viral immunity
RSV is a ubiquitous infection in human neonates. All humans are seropositive for

RSV infections by 2 years of age (Miller et al., 2013). As such, RSV is frequently studied
to understand neonatal viral immunity (Ruckwardt et al., 2014; Schmidt et al.,
2018). These studies can give insights into certain other viral infections like influenza
virus as RSV is also a negative-sense, single-stranded, enveloped RNA virus (Ascough
et al., 2018).

1.7

CD8+ T cells
CD8+ T cells are required for sterilizing immunity to viral infections because they

kill virally infected cells thus disrupting viral replication. Antigen naïve CD8+ T cells
express chemokine receptors CD62L and CCR7 which helps them home to secondary
lymphoid tissues (Ge et al., 2012; Teijeira et al., 2017). Their T cell receptor (TCR) then
can bind to a specific peptide (usually 9-10aa in length) in the context of MHC class I. T
cells specific for viral peptides encounter dendritic cells presenting those peptides on
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MHC class I alongside costimulatory molecules like CD80/86. T cell activation occurs
after engagement of the TCR with MHC class I/ peptide and CD80/86 to CD28 (VeigaFernandes et al., 2000) (Figure 1.3). Cytokines such as type I IFN and IL-12 are made by
antigen-presenting cells and provide a third signal for T cell activation (Galani et al.,
2017).
Activated CD8+ T cells downregulate CCR7 and CD62L to allow them to leave
the lymph node and barring them from reentering secondary lymphoid tissue. They then
upregulate CXCR3, CCR4, CCR9, CCR6, and CCR10: chemokine receptors that
promote trafficking to sites of inflammation. They also upregulate CD44 giving
activated and memory T cells a phenotype of CD44hi CD62Llo when analyzed by flow
cytometry (Lines et al., 2010). Inflamed tissue expresses selectins, ICAMS and VCAMS,
to allow cell adherence and homing and also produce chemokines that bind to CD8+ T
cells and upregulate expression of integrin on the T cell surface. These bind to selectins
and arrest CD8+ T cells at inflamed sites and allow them to invade the tissue (Teijeira et
al., 2017).
The classical effector function of CD8+ T cells is cytotoxicity, but they also
produce copious amounts of IFNγ and TNFα. Activated CD8+ T cells bind to MHC class
I/ peptide complexes on infected cells to direct cytotoxicity. CD8+ T cells induce
apoptosis in infected target cells through several mechanisms. They can activate
Fas/FasL mediated killing as well as expressing TRAIL (Doherty et al., 1997). TRAIL
interacts with the receptors D4/D5 on target cells to induce killing (Shrestha et al., 2012).
CD8+ T cells produce perforin and granzymes for direct killing. Perforin makes pores in
target cells to allow granzymes into the cytoplasm. Granzymes then induce apoptosis
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(Zhao et al., 2018). Immunological synapses form between cytotoxic T cells and target
cells ensuring that delivery of granzymes and other toxins is highly specific. This
synapse is formed from rings of receptors and cytoskeletal elements (Murugesan et al.,
2016).
Even with the highly specific nature of CD8+ killing, these cells are linked to
immunopathology in infections. Mice deficient in IFNγ or mice that receive IFNγ
deficient CD8+ memory cells lose less weight during sublethal infections, suggesting that
these cells play a central role in infection-associated morbidity (Ostler et al., 2002;
Ruckwardt et al., 2010). Ideally, CD8+ T cell activity will be just enough to enable viral
clearance without causing unacceptable damage, but different infections and treatments
can skew this balance. For example, increasing the magnitude of CD8+ T cell responses
to a virus can improve viral clearance while also inducing lethal immunopathology.
CD8+ T cells are powerful effectors and care must be taken when manipulating their
function.
Formation and reactivation of CD8+ memory is essential to the long term health
of the host, and may provide an avenue of attack for vaccinating against pathogens that
can evade antibody mediated immunity (Xiang et al., 2015). After an acute reaction, a
subset of CD8+ T cells will differentiate into memory cells. Some of these will remain in
the tissue as tissue-resident memory cells (Trm) and others will return to circulation as
central memory cells (Tcm) (Ballesteros-Tato et al., 2014; Connors et al., 2018). The
timing of expansion and contraction of CD8+ T cell populations can vary greatly between
infections, but for murine influenzavirus infections, the peak of the CD8+ T cell response
occurs around day 7 of infection in adults and day 10 of infection in pups (Lines et al.,
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2010). Although much attention is given to antibody mediated protection from influenza
infections, memory CD8+ T cells provide substantial protection against subsequent
infections (Wu et al., 2014). Some studies have suggested that this protection can be
heterosubtypic as well, which is usually not the case for antibody mediated protection
(Nguyen et al., 1999). Heterosubtypic viruses share some components, such as internal
proteins, while differing on other ways that usually evade antibody-mediated immunity,
such as the exterior proteins HA and NA. Experiments in mouse models have mostly
used heterosubtypic influenza virus infections rather than CD8+ T cell targeted vaccines
to show that CD8+ memory can reduce disease severity without B cell protection (Liang
et al., 1994). Vaccines targeting CD8+ T cells directly have been shown to protect
against influenza virus as well as other viral pathogens (Knuschke et al., 2014).
Unlike naïve CD8+ T cells, memory CD8+ T cells do not need to traffic to
secondary lymphoid tissues for activation, as they can be activated directly by
inflammatory conditions and infected cells. This allows secondary responses to be much
faster than primary responses (Crowe et al., 2003). During influenza virus infection, Trm
cells rapidly kill infected respiratory epithelial cells, potentially preventing symptomatic
disease altogether (Epstein et al., 1998; Nguyen et al., 1999). In mice, the protection of
Trm is sufficient as blocking Tcm infiltration of the lungs does not compromise
protection (Wu et al., 2014). In humans, CD8+ memory has been shown to promote less
serious disease during influenza infection with heterosubtypic memory providing milder
disease course to patients with the 2009 H1N1 (Xing et al., 2009). Patients infected with
2009 H1N1 also displayed reduced viral shedding during subsequent H3N2 seasonal
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infections (Sridhar et al., 2013). CD8+ memory populations can wane over time (Rai et
al., 2014), but many memory cells persist for at least a decade (Akondy et al., 2017).
1.7.1

CD8+ T cells in neonates
Neonatal CD8+ T cell responses have diminished magnitude and function in part

due to lower expression of CD28 mediated costimulation from neonatal DCs (Ruckwardt
et al., 2014). Studies have shown that with proper stimulation, neonatal CD8+ T cells are
capable of responding in an adult manner to many antigens, suggesting that it is lack of
stimulation rather than T cell intrinsic characteristics that underlie the altered function of
CD8+ T cells in neonates (Fadel et al., 2006).
Regardless of the cause, CD8+ T cells in neonates are hypoactive and contribute
to the vulnerability to infection that young mice and humans experience. There are fewer
CD8+ T cells in the lungs of influenza virus infected pups than adults, and the peak
response is later than in adults (Lines et al., 2010). They produce less IFNγ, perforin and
granzyme, and kill less effectively than adult cells in vivo (Fernandez et al., 2008b).
They also do not move into the airways during infection, resulting in interstitial
pneumonia. Adult airways contain many CD8+ T cells, and some evidence suggests that
this is important for efficient viral clearance (Lines et al., 2010). One study showed that
neonatal CD8+ T cells in infection sites are less functional than circulating CD8+ T cells
in the same animal, suggesting that neonatal CD8+ T cells may also be actively
suppressed in some way during infection (Fike et al., 2018).
Neonates develop memory T cells like adults, but evidence suggests that this
process may differ from adults. Neonatal infections produce fewer tissue-resident
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memory cells with diminished heterosubtypic protection during subsequent infections
(Connors et al., 2018). Additionally, one study showed that neonatal infection with
herpes simplex virus 1 (HSV-1) can “lock in” sub optimal neonatal responses that
interfere with later adult challenges (Rudd et al., 2013). There is evidence that this
memory defect is at least partly due to lower TCR avidity of neonatal memory CD8+ T
cells compared to adult memory CD8+ T cells (Ruckwardt et al., 2011; Rudd et al., 2013).
This suggests that the defect in neonatal T cell memory responses may be T cell intrinsic,
contrasting with the extrinsic activation constraints on neonatal primary responses.
Improving neonatal infection outcomes is partially reliant on safely improving
CD8+ T cell functionality in neonatal responses. While several mechanisms have been
suggested to explain diminished neonatal CD8+ T cell function, the relative importance of
these factors has not been established. Additionally, safe and effective strategies for
circumventing these limitations have not been discovered, although work is being done to
address this issue.

1.8

Dendritic cells
There is some disagreement as to how to definitively distinguish dendritic cells

(DC) from other cell types, but in the lung, we will consider three main subsets. These
are CD103+ or CD11b+ conventional dendritic cells, otherwise called cDC1 and cDC2
respectively, and CD11cdimplasmacytoid dendritic cells (Neyt et al., 2013). Of these, the
conventional DCs also express CD11c as a consistent but not definitive marker and are
most relevant to antigen presentation during viral immunity (Geurts van Kessel et al.,
2008). CD11c is also expressed on alveolar macrophages rendering it insufficient as a
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sole marker of DCs in the lung (Hussell et al., 2014). Plasmacytoid dendritic cells are
often identified by SiglecH expression and produce high levels of type I interferons
making them important during viral infection as well (Liu et al., 2009).
Dendritic cells normally reside in the parenchymal spaces of the lung and monitor
both their immediate surroundings as well as nearby airways through the use of cellular
extensions that extend into the airways. During an infection, dendritic cells must detect
and take up pathogens, mature to an inflammatory DC phenotype and migrate to
secondary lymphoid organs to activate T and B cells (Geurts van Kessel et al., 2008; Ho
et al., 2011). Dendritic cells express Toll-like receptors that allow them to detect
(PAMPs) (Baharom et al., 2015). Viruses such as influenza virus can attempt to subvert
this direct activation through NS1 mediated inhibition of TLR responses, but PAMP
detection is only one of the methods of inducing DC maturation (Bender et al., 1998;
Ioannidis et al., 2012).
The inflammatory environment of a viral infection includes multiple cytokines
and cell types that can activate dendritic cells. Lung epithelial cells can produce IL-1 and
GM-CSF (Willart et al., 2012). GM-CSF is an important growth factor for dendritic cells
and may be essential for their survival (Zhan et al., 2011). IL-1 is a potent activator of
dendritic cells and is necessary for inducing anti-influenza viral CD8+ T cell responses
(Pang et al., 2013). Type I interferons are produced by a variety of cells and are probably
the best at inducing DC maturation (Rudd et al., 2007). NK cells have been shown to
promote DC migration to lymph nodes. (Ge et al., 2012) They also kill virally infected
cells creating infected cellular debris for DCs to phagocytose and process for antigen
presentation (Ge et al., 2012). Finally, complement also plays a role in DC migration,
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particularly C3 which is necessary for migration to the lymph node in animal studies
(Kandasamy et al., 2013).
Dendritic cell migration occurs rapidly after infection through upregulation of
CCR7 receptor, although this change is tempered after 48hrs in influenza virus infection
by upregulation of PGD2 which suppresses CCR7 (Grayson et al., 2007). It is not clear if
this is to prevent further induction of inflammation and avoid excessive pathology or if
this inhibition of migration is caused by the virus.
DCs acquire antigen either through direct infection, phagocytosing pathogens,
phagocytosing infected cellular debris, or direct presentation of peptides processed by
other cells (Bachmann et al., 1996; Chen et al., 2000; Mintern et al., 2015) (Figure 1.4).
Peptides from other cells can simply occupy vacant MHC class I, displace peptides from
MHC class I on the cell surface, or be processed and presented on MHC class I through a
process called cross presentation (Cruz et al., 2017). In the case of influenza virus
infection, DCs are infected directly but they also seem to take up apoptotic virally
infected epithelial cells for cross-presentation on MHC class I (Bachmann et al., 1996;
Hemann et al., 2016).
Monocytes differentiate into dendritic cells in inflammatory conditions and play a
role in continuing CD8+ T cell proliferation and activation in the lungs. The
inflammation generated by these induced DCs contributes significantly to the pathology
experienced by the host (Baharom et al., 2015; Cook et al., 2016). These monocyte
derived dendritic cells are also important for mediating allergic responses in the lungs
(Plantinga et al., 2013).
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1.8.1

Neonatal DCs
Neonatal dendritic cells theoretically perform the same role in the immune

responses of infant humans and mice as they do in adults, but differences can be observed
across multiple aspects of dendritic cell function and phenotype that cause these cells to
behave differently in neonates and adults. On a broad level, neonatal dendritic cells seem
to be less stimulatory than adult DCs at steady state and during infections, expressing
lower levels of costimulatory molecules CD40, CD80/86 and MHC class II in cord blood
and mouse pups (Papaioannou et al., 2019; Qureshi et al., 2005). They are also less
prevalent in neonatal lungs than in adult lungs (Ruckwardt et al., 2014). Neonates have
both CD11b+ and CD103+ dendritic cells, although the CD11b+ population is severely
diminished and CD103+ dendritic cells have diminished function in neonates (Malloy et
al., 2017; Ruckwardt et al., 2018). Plasmacytoid dendritic cells represent a significant
fraction of lung DCs early in life, but this proportion diminishes with age (Dakic et al.,
2004; Sun et al., 2003). Like the other DC subsets, neonatal plasmacytoid dendritic cells
are less active than their adult counterparts (De Wit et al., 2004).
Expression of TLRs is similar on adult and neonatal cells at steady state, but the
response to TLR stimulation is not equivalent. Neonatal dendritic cells produce IL-10,
IL-6 and IL-23 after TLR stimulation rather than IL-12 that is important in Th1 T cell
responses in adults. This shifts towards a more adult-like response of IL-1 and TNF-α
after about a year of life in humans (Malloy et al., 2017). TNF-α production, in
particular, is much lower in neonatal dendritic cells, although adult-like function can be
induced in these cells by pretreatment with IFNγ (van Haren et al., 2016).
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Overall, neonatal dendritic cells are much less proficient at activating T cells and
are strongly biased towards production of more Th2 cytokines (de Kleer et al., 2016).
This is possibly a significant contributing factor to the neonatal susceptibility to viruses
as Th2 cytokines are useful mainly for eukaryotic parasites and suppress the expression
of Th1 cytokines which are important for immunity to intracellular pathogens like viruses
(Graham et al., 1994). Neonatal DCs are also less proficient at processing and presenting
antigens as has been demonstrated in the context of RSV infection (Ruckwardt et al.,
2014). This may have important implications for which antigens neonates can respond to
in a given infection.
Although the general insufficiency of neonatal dendritic cells is well recognized,
it is not clear how important this deficiency is in promoting neonatal susceptibility to
influenza disease. It is also not clear how neonatal DCs effect the use of T cell vaccines
in neonates.
1.8.2

Bone marrow derived dendritic cells
Generation of bone marrow-derived dendritic cells (BMDCs) is a common

method of obtaining large numbers of mouse dendritic cells for study. The general
procedure to create these cells is to isolate bone marrow from mice and then culture it in
the presence of GM-CSF to differentiate hematopoietic precursors into dendritic cells
(Ebrahimi-Nik et al., 2018; Inaba et al., 1992). Many studies have been done with these
convenient cells to examine dendritic cell function and other immune functions. It has
long been recognized that BMDC culture gives rise to a somewhat heterogeneous
population of cells, but the consequences of this as it pertains to assessing dendritic cell
physiology with BMDCs is becoming a cause for concern (Jones et al., 2017).
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Cells obtained from BMDC culture typically express CD11c and MHC class II,
but further examination shows that some of these cells are macrophages and some are
dendritic cells. The DCs in the culture mature more upon stimulation with LPS than the
macrophages, while the macrophages are more sensitive to interferon stimulation (Helft
et al., 2015). Cytokine production can also vary between these subsets (Helft et al.,
2015). These factors make it difficult to use BMDCs as a direct proxy for native
dendritic cells, and studies hoping to examine the in vitro behavior of conventional
dendritic cells should consider using Flt3L to stimulate DC differentiation (Jones et al.,
2017).
However, studies have demonstrated that GM-CSF BMDCs potently stimulate T
cells and can reasonably be used to study T cell activation (Bhattacharya et al., 2011;
Ebrahimi-Nik et al., 2018; Zhan et al., 2011). In regards to the study of neonatal
immunology, BMDCs are adult-like both in stimulatory capacity and phenotype (Qureshi
et al., 2005). Additionally, generating DCs from neonatal bone marrow or cord blood
produces cells that resemble natural adult DCs rather than neonatal DCs, suggesting that
in vitro work characterizing neonatal dendritic cells must be done with isolated DCs ex
vivo (Qureshi et al., 2005).

1.9

Immunodominance
During B and T cell development, naïve cells are generated with a broad range of

antigen specificities. This means that theoretically, during an infection cells exist that
could recognize many different epitopes on a given pathogen. In practice, however, most
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of the adaptive response to a pathogen is directed towards just a few epitopes. This
principle is known as immunodominance. The epitopes with the largest responses are
called immunodominant, and the epitopes with smaller responses are called subdominant
(Belz et al., 2000; Cukalac et al., 2014; Kim et al., 2015). The immunodominance
hierarchy for a particular infection in a particular individual is thought to be the result of
several variables including MHC haplotype, antigen processing and presentation, naïve
antigen specific cell precursor frequency, TCR affinity, and suppression of subdominant
clones by dominant clones (Chen et al., 2000).
MHC haplotype is the easiest factor to understand, although it can be difficult to
study. Simply put, a particular MHC can only present peptides that fit in its groove. As
such, the immunodominance hierarchy of an individual will only include epitopes that
can be presented by that individual’s MHC proteins (Day et al., 2011; Kim et al., 2015).
Antigen availability and processing can be complex and likely plays a key role in
establishing immunodominance hierarchies. There can be much more of one antigen
expressed by a pathogen than another, leading to unequal quantities of various antigens
for presentation to immune cells. For example, there are many NP proteins in an
influenza virus for every PA protein, leading to potentially different levels of these
antigens in infected cells. Additionally, different antigens can be processed differently by
APCs and infected cells. For example, dendritic cells of C57Bl/6 mice infected with the
A/Puerto Rico/8/1934 strain of influenza virus (PR8) can present both immunodominant
peptides NP366-374 and PA224-233, but infected epithelial cells only present NP366-374 (Crowe
et al., 2003).
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Precursor frequency refers to the numbers of naïve cells specific for a particular
epitope. This can vary somewhat between specificities for reasons that are not currently
clear, but there are multiple studies that show that differences in precursor frequency can
significantly shape the immunodominance hierarchy. High precursor frequencies for a
specific epitope can lead to rapid initial expansion, but other factors can overcome this
head start to establish a different hierarchy as the infection progresses (Cukalac et al.,
2014; La Gruta et al., 2010). B and T cell receptors vary widely in their affinity for
binding to an antigen. Higher affinity cells recive higher intensity of TCR stimulation
during a response and will likely proliferate more, becoming dominant in the hierarchy
(Chen et al., 2000; Cukalac et al., 2014). This can override precursor frequency.
Finally, suppression of subdominant clones by dominant clones is likely related to
competition for stimulation (Willis et al., 2006). This happens in lymph nodes as B cells
undergo affinity maturation and among T cells as cells compete for access to dendritic
cells (Schone et al., 2017).
T cell immunodominance is much less predictable outside of inbred mouse strains
and controlled viral infections, but some influenza virus components are often
consistently more immunogenic than others. For example, the NP protein of influenza
virus commonly contains a dominant epitopes for CD8+ T cells in both mice and humans
(Belz et al., 2000; Lee et al., 2019). HA is another common target for CD8+ T cells
across species (Chen et al., 2000). In C57Bl/6 mice infected with PR8, NP366-374 and
PA224-233 are the dominant CD8+ epitopes (Chen et al., 2004a). These will be used
extensively in this study.
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1.10 Flu immunodominance in mice
Most of what is known about immunodominance during influenza virus infection
is from work done in adult C57Bl/6 mice infected with PR8, and of this, most is known
about CD8+ T cell immunodominance hierarchy. B cell immunodominance to influenza
is almost always directed against HA. The mechanics of this process are of great
importance to B cell vaccination efforts and the development of broadly neutralizing
antibodies (Angeletti et al., 2018). CD4+ T cell hierarchy is much less well understood
than B or CD8+ T cell immunodominance due to the difficulty of making MHC class II
tetramers, but this limitation is less of a problem now thanks to technological
improvements. One study suggests that the C57Bl/6 CD4+ T cell hierarchy for PR8
infection contains a broader range of relevant epitopes than the CD8+ hierarchy with
responses to NP, PA, HA, and PB1 (Crowe et al., 2006).
The CD8+ T cell immunodominance hierarchy for C57Bl/6 mice infected with
PR8 is well established in adults. NP366-374 and PA224-233 co-dominate and PB110-34 and
other less common epitopes following as subdominant specificities (Luciani et al., 2013).
The precise proportions of these populations are not consistent, but the magnitudes of the
response to each epitope in an individual animal will follow this established hierarchy.
This hierarchy is set by several factors. PB110-34-specific cells exist at the highest
frequencies prior to infection and dominate early in the infection (La Gruta et al., 2010).
PA224-233-specific cells are the second most common precursor and these also proliferate
early in the infection (Cukalac et al., 2014). NP366-374-specific cells are less common
prior to infection and proliferate later in the infection, but by the peak of the response at
day 7 of infection, NP366-374 cells are fully co-dominant with PA224-233-specific cells
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(Cukalac et al., 2014). Although they are fairly prevalent early in infection, PB110-34specific cells are of low affinity and do not proliferate to the same levels as the dominant
NP366-374 and PA224-233 (Uddback et al., 2016).
Between NP366-374 and PA224-233-specific cells, PA224-233-specific cells in C57BL/6
mice have higher precursor frequency and TCR affinity than NP366-374-specific cells. One
study showed that at high antigen doses, this allows them to dominate over NP366-374
specific cells. At lower antigen doses, the relative effectiveness of presentation of NP366374

and PA224-233 mattered more with NP366-374 dominating over PA224-233 (Luciani et al.,

2013). This is important in memory responses because in secondary infections, NP366-374
becomes strongly dominant over PA224-233. While NP366-374 and PA224-233 are both
presented by dendritic cells, generating PA224-233 and NP366-374 specific cells in the lymph
nodes, only NP366-374 is reliably presented by influenza virus infected respiratory
epithelial cells (Chen et al., 2004a; Crowe et al., 2003). As a result of this, PA224-233
specific cells are not effective for viral clearance and proliferate less in secondary
infections where memory cells may be re-activated directly by infected epithelial cells
(Crowe et al., 2005).
Immunodominance hierarchies influence the outcome of infections. In PR8
infections of C57BL/6 mice, PA224-233 vaccination promotes a strongly PA224-233dominant CD8+ T cell response, but these mice experience increased morbidity compared
even to naïve mice. This was linked to a lack of PA224-233 presentation on infected airway
epithelial cells (Crowe et al., 2005). PB1 vaccination results in similarly poor protection
(Uddback et al., 2016). If vaccination can set hierarches that are ineffective for promoting
protection, then care must be taken with what antigens are selected for subunit vaccines.
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1.10.1 Immunodominance in Neonates
Influenza virus infection immunodominance studies have almost exclusively been
done in adult mice. Studies have suggested that neonatal mice do not always respond
with the same immunodominance hierarchy as adults. This was first shown with RSV
infection of CB6F1 mice as pups responded codominantly to KdM282-90 and DbM187-195
while adults displayed a strongly KdM282-90-dominant response (Ruckwardt et al., 2011).
Ruckwardt et al (2011) proposed that this difference was due to an intrinsic characteristic
of neonatal T cells as adoptively transferred neonatal T cells in adult mice displayed the
same hierarchy. Later, dendritic cells were implicated in establishing the altered
immunodominance hierarchy in RSV infected pups, and that stimulating neonatal
dendritic cells with TLR4 or TLR9 agonists could promote a more adult-like CD8+ T cell
hierarchy (Malloy et al., 2017; Ruckwardt et al., 2014).
Work has also been done investigating the immunodominance hierarchy of
neonates during influenza virus infection. Studies have shown that pups do not respond
to NP366-374 to the same magnitude as adults (Carey et al., 2016). This was linked to T
cell intrinsic factors as transgenic OVA- specific T cells expanded in adult and neonatal
hosts, but nontransgenic cells from neonates did not expand in adults (Carey et al., 2016).
Additionally, Vβ sequencing of pup and adult TCR repertoires demonstrated clear
differences between the age groups with young pups displaying lower diversity of Vβ
usage than adults. Older pups Vβ usage began to resemble adult patterns by day 7 of life
(Carey et al., 2016).
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There is variation on how deficient the neonatal response to NP366-374 is reported
to be in different studies. Studies with 3 day-old pups show very low NP366-374-specific
populations in pups and studies with 2 week-old pups show levels similar to adults
(Carey et al., 2016; Fike et al., 2018; Zens et al., 2017). From these data, it is clear that
neonatal immunodominance can be different than adult hierarchies, but many questions
remain. It is not clear if neonates can be made to respond to adult antigens if given
proper stimulation. It is also unknown whether the neonatal immune environment favors
a different hierarchy for a functional reason. In the case of influenza virus infection, there
is not a clear picture of what actually comprises the neonatal immunodominance
hierarchy other than the lack of NP366-374-specific cells. This study hopes to address these
questions.

1.11 B cells and antibody response
Naïve B cells are generated in the bone marrow and then migrate to secondary
lymphoid organs for activation (Hardy et al., 2001). During influenza infection, virus is
carried to the lymph nodes by dendritic cells where it comes into contact with B cells
(Legge et al., 2003). Activation can also occur in ectopic sites in the infected tissue as
cell aggregates such as inducible bronchus associated lymphoid tissue (iBALT) (MoyronQuiroz et al., 2004). Influenza-specific B cells bind virus with membrane-bound
antibody otherwise known as the B cell receptor (BCR) (Hinton et al., 2008). Some B
cells, particularly the innate-like B1 type, can undergo activation without T cell help, but
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many antigens, including influenza virus antigens, stimulate B2 cells and require T cell
help (Kaji et al., 2012).
Activated B cells may directly differentiate into short-lived plasma cells or migrate
to the germinal centers of the secondary lymphoid tissue (Abbott et al., 2018; Tarlinton et
al., 2013). In the germinal center, activated B cells proliferate and interact with T
follicular helper cells through CD40/CD40L (Chevalier, 2015). They also receive
stimulation from IL-4 and IL-21 (Mastelic et al., 2012). As the B cells proliferate,
somatic hypermutation and class switching occurs. These are the processes where B cells
mutate the BCR gene locus to hone antibody affinity and swap antibody isotypes from
IgM to other types such as IgA or IgG (Abbott et al., 2018). At the end of this process, B
cells producing high quality, virus-neutralizing antibodies will hopefully have been
generated. Some of these cells become memory B cells while others become plasma
cells for antibody generation (Figure 1.5). Some plasma cells migrate to the bone
marrow where they are maintained potentially for the entire lifetime of the organism
(Sallusto et al., 2010). Survivors of the 1918 “Spanish” influenza pandemic were found
to have circulating antibodies against the virus in 2005 (Yu et al., 2008).
Antibodies play arguably the most important role in influenza virus
defense. Antibody against the virus has been shown to provide protection against
subsequent infections provided that the virus has not drifted enough to evade the response
(Sallusto et al., 2010). These antibodies are typically directed against epitopes on HA
and NA. HA-specific antibodies prevent viral entry and are usually dominant, however,
NA-specific antibodies also reduce disease severity by helping to trap influenza viruses
on the sialic acids of the host cells (Kosik et al., 2019; Skehel et al., 2000).
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1.11.1 B cells in neonates
Neonates mount antibody responses to pathogens including influenza virus, but
there are several crucial differences from adult responses (Basha et al., 2014). Neonates
do not respond well to T cell independent B cell stimulation and as such have trouble
responding to antigens like polysaccharide antigens. Vaccines that require responses to
such antigens use polysaccharides conjugated to protein toxins to promote T cell help and
adequate antibody generation (D'Angio et al., 1995). This is not thought to be a problem
for responses to influenza viral proteins because HA is not a polysaccharide antigen.
Neonates have less organized germinal centers and produce less antibody than
adults (Mastelic et al., 2012). These antibodies typically display little affinity maturation
or somatic hypermutation and can be of lower quality than adult antibodies (Debock et
al., 2013; Montecino-Rodriguez et al., 2011). Maternal antibody helps make up for these
deficiencies until B cell immunity is able to mature. Influenza virus naïve mothers, such
as the mice used in these studies, however, cannot protect their pups with maternal
antibody allowing direct analysis of the pup’s response (Waaijenborg et al., 2013).

1.12 CD4+ T cells
CD4+ T cells have diverse functions but during influenza virus infection, they are
primarily important for cytokine production and T cell help to B cells for antibody
production (Doherty et al., 1997). Like CD8+ T cells, naïve CD4+ T cells are activated in
the lymph nodes where they can remain to help B cells or migrate back to the site of
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infection to produce cytokines (Mozdzanowska et al., 1997). CD4+ T cells are vital to
clearance of many infections as is demonstrated by the consequences of their loss during
Human Immunodeficiency Virus (HIV) infection and subsequent development of AIDS
(Utay et al., 2016). Susceptibility to and severity of many infections including influenza
virus infection increases dramatically as CD4+ T cell count falls, pointing to their
essential role in combating these diseases (Sheth et al., 2011).

1.12.1 T cell transcription factors and Th subsets
CD4+ T cells are also called helper T cells and are often divided into subsets
based on function. These subsets have characteristic transcription factors that help set
their transcriptional programs (Figure 1.6). These are Tbet for Th1, Gata3 for Th2,
RORγ for Th17 Bcl6 for Tfh and Foxp3 for Tregs (Figure 1.4).
Tbet drives Th1 function in CD4+ T cells, but it is expressed in other cells as
well. For example, Tbet expression is important for CD8+ T cell, NK cell and Regulatory
T cell (Treg) function (Szabo et al., 2000). Low expression of Tbet has been linked to
decreased CD8+ function in CD31+ CD8+ T cells in neonates (Fike et al., 2018). In T
helper cells, STAT1 and STAT4 are activated by IFNɣ and IL-12 and lead to Tbet
expression. Tbet expression activates Th1 effector function, especially IFNγ production
(Afkarian et al., 2002). It also blocks differentiation into other Th subsets, especially Th2
by suppressing Gata3 expression (Kanhere et al., 2012). Th1 function, especially
expression of IFNγ, is important for activating macrophages and driving immunity
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against intracellular pathogens (Bettelli et al., 2004). Th1 immunity is considered more
inflammatory than Th2 in regard to classic immunopathology (Graham et al., 1994).
Gata3 drives Th2 function in CD4+ T cells, but it is expressed in many other cells
and may drive a wide range of critical functions (Wan, 2014). In T cells, IL-4 drives
STAT6 to activate Gata3. This in turn leads to Th2 effector functions such as production
of IL-4, IL-5, and IL-13. It also blocks differentiation into other Th subsets, especially
Th1 by suppressing Tbet expression (Kanhere et al., 2012). Th2 cytokines stimulate
eosinophils, basophils, mast cells and B cells and are associated with allergic and antiparasite reactions (Chen, Hou, et al., 2018).
IL-6 and IL-23 act through STAT 3 and drive expression of RORγ which
activates Th17 function (Yang et al., 2007). RORγ is thought to be opposed to Treg
function and Foxp3 expression, although Foxp3/RORγ double positive cells have been
found, particularly in the case of pathogenic inflammation (Ren et al., 2017). RORγ
drives production of the characteristic Th17 cytokine IL-17. IL-17 is a proinflammatory
cytokine that helps to attract innate immune cells, particularly neutrophils, to the site of
inflammation (Veldhoen, 2017). Th17 cells are important in reactions to extracellular
pathogens and fungi. They are also central players in many forms of autoimmunity (van
der Waart et al., 2014).
Bcl6 was discovered in T follicular helper cells (Tfh) where it acts as a
transcriptional repressor and opposes the function of Blimp-1 (Chevrier et al.,
2017). Bcl6 is essential for Tfh differentiation and function and actively inhibits
differentiation into other Th subsets by suppressing expression of transcription factors
like Tbet, Gata3 and RORγ (Chevrier et al., 2017). Tfh cells express CXCR5 and PD1 as
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well as high levels of CD40 and IL-21 for B cell activation (Chevalier, 2015). Tfh reside
in the T cell zone of germinal centers in secondary lymphoid tissues and provide help for
B cell activation, maturation, and class switching (Debock et al., 2013).
Foxp3 is closely associated with Treg differentiation and function. It drives Treg
effector functions and is necessary for the maintenance of these cells (Zhou et al.,
2009). In humans, Foxp3 is expressed transiently in activated T cells making it
unreliable as a sole marker of Tregs, but in mice, it is thought to be exclusive to Tregs
(Devaud et al., 2014; Sakaguchi et al., 2010).
1.12.2 Neonatal CD4+
Neonatal CD4+ T cells have been studied extensively and this work clearly shows a
strong Th2 bias in neonatal T cell function with production of IL-4, IL-5 and IL-13
production predominating (Adkins et al., 1998). Some evidence suggests that IFNγ is
epigenetically repressed in children under 6 months of age, although strong stimulation
can overcome this restriction (Verhoeven, 2019; Verhoeven et al., 2016). Similarly, IL-4
is epigenetically favored in neonatal cells creating an environment where IL-4 strongly
dominates the Th1/Th2 balance (Adkins et al., 1992). The Th2 bias in neonates is likely
part of a toleregenic environment that helps prevent immunopathogenic IFNγ responses,
but it may also be related to the development of asthma and other atopic conditions after
childhood infections (Miller et al., 2011; Tang et al., 1994).
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1.13 Regulatory T cells
Regulatory T cells (Tregs) are a subset of CD4+ T cells that play an important role
in immunosuppression and tolerance (Kim et al., 2007). In mice, the transcription factor
Foxp3 is sufficient to identify CD4+ T cells that are Tregs. In humans, Foxp3 can be
expressed by other cells, requiring cells to also be CD25hi and CD127lo before they may
be considered Tregs (Devaud et al., 2014). Ultimately, demonstration of suppressive
capability is the final gold standard of whether a T cell is a Treg, but in mice, Foxp3
expression is widely accepted as a good marker.
Unlike conventional T cells, Tregs perform an immunosuppressive role in the
immune system through a variety of mechanisms. Tregs are generated in the thymus
from a selection of autoreactive cells that would otherwise be negatively selected during
T cell development (Dhamne et al., 2013; Sakaguchi et al., 2010). Tregs can also be
generated in the periphery with non-self TCRs. These are thought to help control
activated immune responses (Bedoya et al., 2013).
Tregs utilize several mechanisms to suppress immune responses including IL-2
sequestration, APC deactivation, direct killing of effectors, and production of antiinflammatory cytokines (Vignali et al., 2008). Tregs express high levels of CD25, the
high affinity IL-2 receptor subunit, and this allows them to compete with effector T cells
for available IL-2 (Leon et al., 2014). Tregs have been shown to decrease APC function
by simply occupying autoreactive MHC- peptide complexes or downregulating APC
expression of costimulatory molecules (Rueda et al., 2015). Surprisingly, Tregs have
also been shown to directly kill effector cells using a granzyme system similar to CD8+ T
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cells (Gondek et al., 2005). The most well recognized mechanism of Treg suppression is
production of anti-inflammatory cytokines, particularly TGFβ and IL-10 (Yu et al.,
2017). IL-10 defecient mice spontaneously generate ulcerative colitis (Kuhn et al.,
1993). Overall, mice that lack Tregs and humans with Treg defects manifest rampant
multi-organ autoimmunity placing Tregs as a central mediator of tolerance (Bacchetta et
al., 2016).
While Tregs express Foxp3 as a central regulator of their function, they have also
been shown to express conventional T cell transcription factors like Tbet, Gata3, and
RORγ (Kluger et al., 2016; Yu et al., 2015). There are several suggested explanations
and consequences of this expression. Tregs expressing RORγ are thought to be cells that
are losing suppressive function and transitioning to Th17 cells in cases of pathogenic
inflammation (Ren et al., 2017). Similar theories have been proposed for Tbet and Gata3
expression (Koch et al., 2012; O'Hagan et al., 2017), but other studies have shown that
Tbet and Gata3 are essential for Treg function as knocking out both these transcription
factors in Foxp3+ T cells results in rampant autoimmunity (Wohlfert et al., 2011; Yu et
al., 2015). Specifics of what these functions are is unclear, particularly for neonates.
1.13.1 Tregs in Neonates
Almost all Tregs in neonates are thymus-derived which is consistent with the
overall lack of antigen experience in the young immune system (Gervassi et al., 2014).
Neonatal Tregs are less potent at suppressing T cells and dendritic cells than adult Tregs
(Rueda et al., 2015), but they are still required to prevent catastrophic autoimmunity in
newborn humans and mice (Kim et al., 2007). Scurfy mutant mice lack Foxp3 and
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therefore lack Tregs (Godfrey et al., 1991). Hemizygous scurfy mice die by three weeks
of age from multi-organ autoimmunity.
Tregs are essential for a fetus to prevent rejection by the maternal immune system
(La Rocca et al., 2014), and even after birth, neonatal T cells may be predisposed to
becoming Tregs after TCR stimulation (Wang et al., 2010). Perhaps because of these
factors, Tregs are more numerous in many tissues including the neonatal lung than in
adult lungs (Oliphant et al., 2015).
1.13.2 Depletion of Tregs and infection
Given the powerful role of Tregs in preventing autoimmunity and controlling
inflammatory responses, considerable effort has been devoted to understanding whether
Tregs constrain host responses to pathogens in ways that are detrimental to clearance.
The simplest way to study this is to deplete Tregs from mice using anti-CD25 antibodies
or use Foxp3 DTR mice that express the diphtheria toxin receptor under the control of the
Foxp3 promoter. Administering diphtheria toxin to these mice specifically depletes
Tregs (Betts et al., 2011; Wang et al., 2016).
The effect of Treg depletion on infections varies with the pathogen used. Treg
depleted mice clear Listeria monocytogenes faster than undepleted mice (Heit et al.,
2008). Additionally, herpes simplex virus 1 infected mice had lower viral titers after
Treg depletion (Fernandez et al., 2008a). Other infections show the opposite. RSV
infected mice have higher viral burdens after Treg depletion (Lee et al., 2010), and we
have shown that pups lacking Tregs were not able to clear influenza virus (Oliphant et al.,
2015).
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Treg depletion undoubtedly increases inflammation in infected animals, and this
increases immunopathology across nearly all infections tested (Suvas et al., 2004). This
inflammation may not always be productive, however, as studies have reported
disruptions in adaptive immune responses after Treg depletion. Tfh function is
compromised by Treg depletion in influenza virus infections leading to lower titers of
virus-specific antibody (Leon et al., 2014). This study was done in adults and did not test
viral clearance, but other studies have suggested that Treg depletion does not alter
influenza disease course in adults (Betts et al., 2011). In adult RSV infection, the
increased viral burden observed in Treg depleted animals was associated with a delayed
CD8+ T cell response (Ruckwardt et al., 2009).
Treg clearly influences the response to influenza in both pups and adult mice, but
the reasons for this are unclear in pups. The observation that Treg depletion did not alter
the course of influenza virus infection in adult mice while compromising viral defense in
pups suggests either that different mechanisms are at work in young animals or that the
defects in antibody and germinal center formation in adults are more serious in the
already low-function neonatal immune response. This is a technically difficult question
to answer given the fragility of infected pups made even sicker by Treg depletion, but this
study attempts to shed some light on the issue.

1.14 Overall hypothesis
The overall hypothesis of this dissertation is that neonatal immunity can be
manipulated to improve outcomes during influenza infection. Chapter 3 will characterize
neonatal immunodominance to influenza virus infection address whether neonatal
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immunodomicance can be manipulated. Chapter 4 will explore whether PA224-233specific CD8+ T cells can protect pups against influenza virus infection. Chapter 5 will
examine whether regulatory T cells (Tregs) are required for anti-influenza virus antibody
production, and characterize the role of Gata3 in Treg function during influenza virus
infection.
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Figure 1.1 Influenza A virus structure.
Influenza A virus is enveloped by a lipid bilayer that contains the surface proteins
hemagglutinin (HA), neuraminidase (NA), and the proton channel matrix protein 2 (M2).
Matrix protein 1 (M1) forms the capsid. Inside the virion are eight RNA genome
segments coated with nucleocapsid protein (NP) called ribonucleoprotein complexes
(RNP). The RNPs are associated with the three components of the viral RNA dependent
RNA polymerase, polymerase basic protein 1 (PB1) polymerase basic protein 2 (PB2)
and polymerase acidic protein (PA).
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Figure 1.2 Influenza A virus infection cycle.
Hemagglutinin (HA) binds to sialic acids on host cells before being endocytosed.
Acidification of the endosome induces a conformational change in HA that allows fusion
with the endosome membrane and uncoating of the viral genome. Viral gene segments
are transferred to the nucleus and undergo replication into mRNA and + sense template
for viral genome replication. Viral proteins are synthesizes in the cytoplasm and new
ribonucleoprotein complexes (RNPs) are packaged. Virions are assembled at the host
cell membrane and bud from the surface after RNPs are packaged. NA cleaves host sialic
acids to allow release of the virus.
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Figure 1.3 Dendritic cell antigen acquisition.
Adapted with permission from (Mintern et al., 2015)
During influenza virus infection, respiratory epithelial cells become infected and lyse
releasing cell fragments and infectious viruses. Dendritic cells may endocytose cellular
debris (a) or become infected (b) to acquire influenza antigens. Endocytosed antigens are
processed and presented on MHC class II or cross presented on MHC class I for
activation of T cells. Infected DCs process viral proteins through autophagy and directly
present viral peptides on MHC class I to CD8+ T cells.
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Figure 1.4 T cell activation.
During infection, dendritic cells are activated by pathogen-associated molecular
patterns (PAMPs) and acquire antigens in the inflamed tissue. They then migrate to
lymphoid tissue to interact with T cells. Activated dendritic cells present peptides bound
to MHC class I and MHC class II and express costimulatory molecules like CD40L and
CD80/86. Naïve CD4+ and CD8+ T cells interact with MHC class II and MHC class I
respectively with the aid of the CD4+ and CD8+ proteins. CD28 interacts with CD80 or
CD86 to provide a second signal for activation. CD40/CD40L interaction provides
costimulation as well. Activated dendritic cells produce cytokines like IL-12 and type I
interferons that impact T cell activation and polarization into various T helper subsets. T
cells produce IL-2 to promote T cell survival and proliferation.
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Figure 1.5 Germinal center reaction.
Naïve B cells encounter antigen in the periphery and become activated. They migrate to
lymph nodes and proliferate to form germinal centers (GC). Clones expand in the dark
zone of the GC and undergo somatic hypermutation of the B cell receptor gene. B cells
migrate to the light zone for interaction with follicular T helper cells and GC dendritic
cells to select for mutations that improved antibody affinity and destroy mutants that
reduced antibody affinity. After affinity maturation, B cells with T cell help can undergo
class switching and differentiate into plasma cells or memory B cells.
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Figure 1.6 T helper subsets.
Naïve CD4+ T cells differentiate into Th subsets upon activation. Th1 cells are polarized
by IFNγ, express the transcription factor Tbet, and produce IFNγ. Th2 cells are polarized
by IL-4, express the transcription factor Gata3 and produce IL-4 and IL-13. Th17 cells
are polarized by TGF-β, IL-6 and IL-23, express the transcription factor RORγ and
produce IL-17. T follicular helper (Tfh) cells are polarized by IL-6 and IL-21, express
the transcription factor Bcl-6, and produce IL-21 while expressing CD40. Regulatory T
cells (Tregs) are polarized by IL-2 and TGF-β, express the transcription factor Foxp3,
and produce IL-10 and TGF-β while expressing CD25.
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CHAPTER 2. MATERIALS AND METHODS
2.1

Mice
C57BL/6J (Stock #000664), Gata3tm1.1Mbu/J (Stock #028103), B6.129(Cg)-

Foxp3tm4(YFP/icre)Ayr/J (Stock #016959), and B6.129(Cg)-Foxp3tm3(DTR/GFP)Ayr/J (Stock
#016958) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). B.CgFoxp3sf (Stock #004088) (scurfy) heterozygous female mice were also purchased from
The Jackson Laboratory and bred with wild-type C57BL/6 males under specific pathogen
free conditions. Scurfy mutation was determined by flow cytometry for male pups and
Foxp3 cre/ Gata3 flox status was determined by PCR after breeding as described
below. Timed pregnancies were generated by co-housing female mice for two weeks to
synchronize estrus before co-housing with one male to two females for breeding. All
mice were maintained at the University of Kentucky Division of Laboratory Animal
Research facilities with the approval of the University of Kentucky Institutional Animal
Care and Use Committees (IACUC) and Institutional Biosafety Committees. Male and
female pups were used in all experiments.

2.2

Phenotyping and genotyping of scurfy and Gata3-Foxp3+ mice
Presence of scurfy null mutation of Foxp3 on the X chromosome was confirmed by

flow cytometry of TBLN CD4+ T cells. Scurfy mice were identified by the complete lack
of Foxp3 intracellular staining in CD4+ cells.

Foxp3tm4(YFP/icre)Ayr/J genotype was determined by PCR on tail snip DNA with the
primers CGGGTCAGAAAGAATGGTGT and CAGTTTCAGTCCCCATCCTC
according to the protocol provided by The Jackson Laboratory.
Gata3tm1.1Mbu/J genotype was determined by PCR on tail snip DNA with the
primers TGTCAGGGCACTAAGGGTTG and CACAGTGGGGTAGAGGTTGC
according to the protocol provided by The Jackson Laboratory.
B6.129(Cg)-Foxp3tm3(DTR/GFP)Ayr/J were maintained as hemizygous transgenic
animals and required no genotyping.

2.3

Viral stocks and influenza virus peptides
Influenza viruses, A/Puerto Rico/8/34 (H1N1) (PR8) and A/X-31(H3N2) (X-31)

(originally provided by Linda Cauley, University of Connecticut Health Center) were
grown in 10-day-old specific-pathogen-free embryonated chicken eggs (Charles River) as
has been described before (Cottey et al., 2001). Both viral stocks were verified to contain
only IAV by RADIL (University of Missouri). Viral titers were measured in egg
infectious doses (EID50) by titrated infectious doses in new eggs as described before
(Cottey et al., 2001). Viral aliquots were stored at -80⁰C.

NP366-374, PA224-233, PB1 (10-34) and PB1-F2 (62-70) were purchased from
GenScript as custom peptides (Table 2.1).
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2.4

Infections
Mice were given LD10 doses of PR8 or HKx31 intranasally (i.n.) under isoflurane

anesthesia. The virus was thawed and diluted in HBSS for delivery. Volume was 10μL
for pups and 50μL for adults. For PR8, this was equivalent to 2.5 (EID)50/g of body
weight for adults and 0.25(EID)50/g of body weight in pups. For HKx31 this was
equivalent to 10 (EID)50/g of body weight in adults and 1 (EID)50/g of body weight in
pups. Following infections, all mice were monitored daily for body weight and
euthanized by CO2 or isoflurane asphyxiation in accordance with the University of
Kentucky IACUC’s criteria.

For heterosubtypic infections, primary infections were performed with PR8 or
HKx31 as described above. For secondary infections, an LD100 dose was delivered
intranasally under isoflurane anesthesia. This corresponded to 25 (EID)50/g of body
weight for PR8 and 100 (EID)50/g of body weight for HKx31. Lethal doses were
determined by dose dependent survival studies in pups and adults for both HKx31 and
PR8.

2.5

Cell isolation
Lungs were lavaged five times with cold HBSS/3mM EDTA to extract alveolar

cells as described before (Sun et al., 2017). Lungs were excised and minced before
digestion at 37⁰C with 50U/mL DNAse (Sigma) and 1mg/mL collagenase (Sigma) in
RPMI (ThermoFisher) with 3% FCS (Atlas Biologicals, Fort Collins, CO). Lungs were
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collected in RPMI with 3% FCS and TBLN were collected in cold HBSS. Single-cell
suspensions of lungs and TBLN were generated separately by pressing tissues though
70μm cell strainers (BD Biosciences, San Jose, CA). Red blood cells were lysed using
ammonium chloride/potassium (ACK) lysis buffer. Cells were then washed and
resuspended in HBSS (ThermoFisher).

2.6

Flow Cytometry
Surface staining was performed on 5x105 to 106 cells with fluorochrome conjugated

antibodies or MHC-I tetramers in PBA buffer (phosphate-buffered saline containing
0.1% BSA and 0.02% NaN3) for 30min at room temperature (Table 2.2). Cells were
fixed with 10% formalin at room temperature for 20min before wash with HBSS and a
spin at 300xg for 7 min.

For intracellular cytokine staining, cells were stimulated for 4hrs at 37C with
50ng/mL PMA (Enzo Life Sciences) and 1 𝛍𝛍g/mL of ionomycin (Sigma). Brefeldin A

(10 𝛍𝛍g/mL final concentration) was added 2hrs after simulation to trap cytokines in the

golgi apparatus. Cells were surface stained at room temperature as described above with
the addition of 10𝛍𝛍g/mL Brefeldin A (Sigma) to the PBA. Cells were fixed 5% neutral
buffered formalin (Sigma), permeabilized with saponin (5mg/mL) and stained for 30min
with antibodies specific for IFNᵧ. Analysis was performed by flow cytometry with an
LSRII cytoflurometer (BD Biosciences, Mountain view, CA). 50,000 events were
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collected for each sample and analysis was performed with FlowJo software (Tree Star,
Inc., Ashland, OR).

For intracellular transcription factor staining, cells were surface stained as
described above before being fixed and permeabilized with the eBioscience Foxp3/
transcription factor staining buffer set (ThermoFisher cat # 00-5523-00) according to the
manufacturer's instructions. Cells were stained with anti-Foxp3, anti-Tbet, anti-Gata3 or
anti-RORɣt for 30min at room temperature. Analysis was performed by flow cytometry
with an LSRII cytoflurometer (BD Biosciences, Mountain View, CA). 50,000 events
were collected for each sample and analysis was performed with FlowJo software (Tree
Star, Inc., Ashland, OR).

2.7

Antigen presentation assays
Bone marrow-derived dendritic cells were generated by flushing the femurs of

adult, female C57BL/6 mice with cold RPMI to isolate bone marrow. Red blood cells
were lysed with ACK as described above, and bone marrow was plated with 10 mL
RPMI containing 10%FCS, 0.1% 2-Mercaptoethanol and 1ng/mL GM-CSF
(Sigma). After 10 days, BMDCs were washed with RPMI and incubated for 1hr at 37⁰C
and 5% CO2 in 14mL polypropylene culture tubes in RPMI containing 10%FCS with
either PR8 at a 0.1 multiplicity of infection, 0.1 mM peptide, or left untreated. Treated
BMDCs were cultured 1:5 with lymphocytes taken from lymph nodes of mice 10 days
post-infection and prepared as a single cell suspension as described above. After 3 days,
plates were centerfuged at 300xg for 7 min and supernatants were collected and frozen at
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-80⁰C. Supernatant was later analyzed for IFNᵧ by ELISA per the manufacturer's
instructions (eBiosciences).
For lung tissue presentation assays, lungs were taken from naïve 2-day-old pups
and adults and digested as specified before. Spleens were taken from PR8 infected adults
at day 7 post infection and CD8+ T cells were isolated by CD8+ T cell enrichment column
(Cat# MCD8C-1000, R&D). 104 CD8+ T cells were co-cultured with 105 naive lung
digest with and without peptide or co-cultured with peptide loaded BMDCs. After 3
days, supernatants were frozen at -80⁰C and later analyzed for IFNᵧ by ELISA (Cat#
BMS606 ) per the manufacturer's instructions (ThermoFisher)

2.8

CpG vaccination

CpG vaccination was prepared with 1mg/mL NP366-374, 1mg/mL PA224-233, and 0.4mg/mL
CpG (OD2395, Invitrogen) mixed 1:1 with Montinide (Seppic, Henrico County VA) to
form an emulsion. Vaccine was injected i.p. to mice on day 0 and day 7 of vaccination.

2.9

Adoptive transfer of PR8 infected or peptide pulsed BMDCs
BMDCs were generated as described above. After 9 days, BMDCs were

stimulated with 50ng/mL LPS (Sigma) overnight at 37⁰C and 5%CO2. Then BMDCs
were washed once with RPMI before resuspension in RPMI with 10% FBS and incubated
with 107 EID PR8 or HBSS per 106 BMDC for 1hr at 37C, 5%CO2. BMDCs were then
washed once with RPMI and incubated for an additional 3hrs at 37C. BMDCs were
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washed once with RPMI before resuspension in RPMI with 10% FBS and adoptive
transfer. Peptide-pulsed DCs were incubated for 1hr with 1mM fina concentration of
peptide and then washed once with RPMI before adoptive transfer. 104 BMDCs in 50μL
of RPMI were injected I.P. to pups on day 0 of infection or vaccination. 5x104 BMDCs
were transferred to adults on day 0 of vaccination.

2.10 Hemagglutination inhibition assay.
Hemagglutinin inhibition assays were performed as described before (Cottey et al.,
2001). Briefly hemagglutination capacity for viral stocks was determined by titrating
virus with 1% chicken red blood cell (CRBC) solution (Colorado Serum Company).
Stock virus was diluted to 4 hemagglutination units (HAU) and mixed with serial
dilutions of serum from infected mice. 1% CRBC was added after 30min at room
temperature. Agglutination was observed after a 40min incubation at room temperature.

2.11 Statistics
Data represent the mean ±SD or SEM for 3-10 mice per group and at least 2
separate trials were performed for each experiment. Statistical analysis was performed
with SigmaPlot software (San Jose, CA). Student’s t-tests or two-way analysis of
variance (ANOVA) were performed to test for differences followed by Holm-Sidak posthoc test for pairwise comparisons. Mann-Whitney rank sum tests or Kruskal-Wallis oneway ANOVA on ranks were performed at each time point followed by Dunn’s pairwise
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post-hoc test if normality or variance tests failed. p<0.05 was considered statistically
significant.
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Table 2.1 Influenza peptides
Peptide

Sequence

NP366-374

ASNENMETM

PA224-233

SSLENFRAYV

PB110-34

SSYRRPVGI

PB1-F262-70

LSLRNPILV
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Table 2.2 Antibodies used for flow cytometry
Antibody/ tetramer

Flurocrome or
flurophore

Vendor/Cat. No./Clone

Anti-mouse CD4

PerCP-eFluor710

Thermo/ e 46-0041 / GK1.5

Anti-mouse CD8

APC

Thermo/ e 17-0081/ 53-6.7

Anti-mouse CD8

FITC

Thermo/ e 11-0081/ 53-6.7

Anti-mouse CD19

PE

Thermo/ e 12-0193/ 1D3

H-2D(b) Influenza A NP 366-374
ASNENMETM tetramer
H-2D(b) Influenza A PA 224-233
SSLENFRAYV tetramer
Anti-mouse CD44

PE

NIH Tetramer Core Facility

Alexa 488

NIH Tetramer Core Facility

FITC

Thermo/ e 11-0441/ IM7

Anti-mouse CD62L

APC

Thermo/ e 17-0621/ MEL-14

Anti-mouse IFNγ

eFluor450

Thermo/ 48-7311-82/ XMG1.2

Anti-mouse Foxp3

APC

Thermo/ e 17-5773/ FJK-16s

Anti-mouse Tbet

PE

Thermo/ 12-5825-82/ 4B10

Anti-mouse Gata3

PE

Thermo/ 12-9966-42/ TWAJ

Anti-mouse CXCR5

FITC

Thermo/ 11-9185-42/ MU5UBEE

Anti-mouse PD-1

BV510

BioLegend/ 135241/ 29F.1A12

Rat IgG1 k isotype

PE

Thermo/ 21-4301-83/ eBRG1

Rat IgG2a k isotype

PE

Thermo/ 12-4321-83/ eBRG2a

Rat IgG1 k isotype

APC

Thermo/ 17-4301-83/ eBRG1

Rat IgG1 k isotype

eFluor450

Thermo/ 48-4301-83/ eBRG1
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CHAPTER 3. THE CD8+ T CELL IMMUNODOMINANCE HIERARCHY IS
ALTERED IN NEONATES DURING INFLUENZA VIRUS INFECTION
3.1

Introduction
Neonates and children are vulnerable to influenza virus infection, suffering

significant morbidity and even mortality as a result of this common infection (Antonova
et al., 2012; Nelson et al., 2014; Reed et al., 2015). This remains the case despite yearly
vaccination efforts (Neuzil et al., 2002; Thommes et al., 2017). Children under 6 months
of age cannot be vaccinated for influenza, and even after that period, two injections are
required to confer protection instead of the one adults require (Sridhar et al., 2015). As a
result, influenza causes more hospitalizations and deaths in American children than any
other vaccine-preventable disease (Reed et al., 2015).
The neonatal immune response exhibits a variety of differences from the adult
response that may underlie the observed vulnerability of infants to influenza virus
infection (Adkins et al., 2002; Adkins et al., 1998; Basha et al., 2014; Ruckwardt et al.,
2014). We have shown that CD4+ and CD8+ T cell migration into the lungs is delayed in
mouse pups during influenza virus infection (Lines et al., 2010). Additionally, these T
cells accumulate in the interstitium of murine lungs instead of moving into the alveolar
spaces as is seen in adults (Lines et al., 2010). This is similar to the interstitial
pneumonia observed in severe human infant influenza virus and RSV infections
(Welliver et al., 2007). These diminished T cell populations correlate with changes in
function as well, with neonatal T cells displaying reduced cytotoxicity and cytokine
production compared to adult cells in a variety of viral illnesses (Adkins et al., 2002;
Ruckwardt et al., 2014; You et al., 2008). Intriguingly, neonatal T cells can respond
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robustly like adult cells given adult APCs (Fadel et al., 2006; Smith et al., 2014). We
have seen in our murine model of influenza infection that with this diminished immune
function, pups struggle to clear even minute quantities of virus (Lines et al., 2010).
Understanding the functional aspects of the neonatal influenza virus response is
necessary for effectively designing specific treatments that improve infection outcomes
while avoiding excess inflammation in this fragile population.
During T cell receptor (TCR) generation, a diverse repertoire of T cell specificities
is created (Carey et al., 2017). During an immune response, however, most of the
expanded T cell population derives from clones specific for a few of the many potential
epitopes in a given antigen: a principle known as immunodominance (Chen et al., 2000;
Crowe et al., 2003; La Gruta et al., 2010). In C57Bl/6 mice, the peptides NP366-374 and
PA224-233 are known to be co-dominant during adult A/PR/8/34 (PR8) influenza virus
infections, but it has been suggested that immunodominance can be shifted in neonates
(Carey et al., 2016; Ruckwardt et al., 2014). Neonates respond co-dominantly to epitopes
from the M2 and M proteins of respiratory syncytial virus compared to the strong M2
restricted response in adult infections (Ruckwardt et al., 2011). Similarly, in influenza
virus infection, published evidence as well as our preliminary data suggested that pups do
not respond to the NP366-374 epitope (Carey et al., 2016). CD8+ T cells are typically
considered essential to effectively clear primary influenza virus infection (Wu et al.,
2014), but pups are so exquisitely sensitive to the virus that they may simply not produce
an effective CD8+ T cell response during this infection. Nonetheless, we were interested
in investigating what, if anything, neonatal CD8+ T cells were responding to instead of
NP366-374.
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In this study, we identify what may be the immunodominant peptide in neonatal
C57Bl/6 murine infections using an acute model of influenza virus infection. Responses
were compared between adult mice and pups to evaluate CD8+ specificity in primary and
secondary responses. We found the primary neonatal response to be strongly biased
towards PA224-233 rather than the adult codominant response to NP366-374 and PA224-233.
CD8+ T cell specificity is less predictable in the secondary infections of mice first
infected as neonates compared to mice first infected as adults. Some mirror the strong
dominance of NP366-374-specific CD8+ T cells, while others exhibit NP366-374 and PA224-233
codominance or even PA224-233 dominance alone. Regardless of hierarchy, CD8+ memory
was less effective in mice first infected as pups. Additionally, we found that transfer of
PR8-loaded bone marrow-derived dendritic cells improved viral clearance in pups as well
as promoting NP366-374-specific CD8+ T cells. We believe these data support previous
findings about neonatal T cell specificity and demonstrate that the immunodominance
hierarchy can be manipulated to some degree. These data also show the importance of
examining the neonatal period separately from adult responses when establishing an
immunodominance hierarchy. This notion has important implications for the
development of subunit vaccines for patients of different ages, as well as furthering our
general knowledge of viral defense in early life.
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3.2
3.2.1

Results
Neonates do not produce CD8+ T cells specific for NP366-374 during primary
influenza virus infection and instead respond to PA224-233
The CD8+ immunodominance hierarchy for adult C57Bl/6 mice has been clearly

demonstrated during PR8 infection (Belz et al., 2000; Crowe et al., 2003), but much less
is known about neonatal CD8+ T cell specificity. We wanted to test whether the
dominant adult response to NP366-374 could be recapitulated in pups. We infected 2-dayold or 8-week-old mice with an LD10 dose of PR8 influenza virus. CD8+ T cells were
isolated from the lymph nodes of pups and adults at day 10 of infection and stimulated
with BMDCs loaded with NP366-374, PA224-233, PB110-34 subunit of the viral polymerase
(PB1) or PB1-F262-70 protein encoded by the +1 alternative open reading frame in the
PB1 gene (PB1-F2). IFNγ production was measured in supernatants at day 3 of culture by
ELISA. Neonatal cells produced more IFNγ in response to PA224-233 and PB110-34 than to
NP366-374 (Figure 3.1 A). Conversely, the adults displayed similar responses to NP366-374,
PA224-233 and PB110-34 (Figure 3.1 A). There was some variability in the PB110-34 response
between trials with another experiment showing much lower response in both pups and
adults (data not shown).
To further test the shift in the neonatal CD8+ T cell response, we infected 2-dayold or 8-week-old mice with an LD10 dose of PR8 influenza virus and analyzed wholelung digest and bronchial alveolar lavage (BAL) CD8+ T cells for antigen specificity by
flow cytometry using tetramers for NP366-374 and PA224-233. At 10 days post-infection,
pups displayed an essentially absent NP366-374- specific CD8+ T cell response compared to
adults in both lung digest (Figure 3.1 B, D) and BAL (Figure 3.1 C, E). This is consistent
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with previous findings suggesting that pups do not respond to NP366-374 during PR8
infection. (Carey et al., 2016).
Adults also displayed PA224-233-specific populations in addition to the NP366-374specific cells. Although pups did not respond to NP366-374, they did display robust PA224233-specific

cell populations in the lung digest (Figure 3.1 F, G). There was some

variation amongst the pups as to what percentage of the CD8+ T cells in the lung and
BAL were PA224-233-specific, but none of the PA224-233-dominant mice showed any
appreciable NP366-374 response (Figure 3.1 F, G). As expected, neonates displayed fewer
overall CD8+ T cells in the alveolar spaces during infection, which translates to lower
overall numbers of antigen-specific T cells in this location as well (Figure 3.1 I). This is
consistent with our previous work suggesting that neonatal CD8+ T cells are unable to
efficiently enter the airways during infection (Lines et al., 2010). These data indicate that
pups display a PA224-233 response instead of the adult co-dominant NP366-374 and PA224-233specific response.
3.2.2

Neonatal influenza virus infection generates weak T cell memory and results in
altered CD8+ specificity during secondary infection
A significantly altered immunodominance hierarchy during a primary infection

likely impacts the specificity of the memory response generated by that infection (Chen
et al., 2004a; Crowe et al., 2003). We used heterosubtypic influenza virus infections to
examine memory responses in mice first infected at 2 days or 8 weeks of age. HKx31 is
an artificial reassortant influenza virus strain that shares all internal components
including NP366-374 and PA224-233 with PR8 while differing with respect to exterior
components like HA and NA. HKx31 is H3N2 and PR8 is H1N1. Therefore, only T cell
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memory to the internal components of either virus will be protective when mice are
challenged with the other virus. Mice were infected with a LD10 dose of HKx31 or PR8
and then rechallenged 2 months later with a lethal dose of PR8 or HKx31, respectively.
Mice first infected as pups demonstrated more weight loss than mice first infected as
adults, although both groups were better protected than naïve animals. All naïve mice
were euthanized by day 7 of infection when they had lost 20% of starting body weight
(Figure 3.2 A). Mice first infected as pups had significantly fewer IFNγ positive CD4+
and CD8+ T cells than mice first infected as adults at day 9 of infection (Figure 3.2 B).
Mice first infected as pups showed similar numbers of CD8+ T cells in the lung digest to
the numbers displayed by mice first infected as adults (Figure 3.2 C), but they had fewer
CD8+ T cells in the BAL at day 5 of infection (Figure 3.2 D).
The secondary response immunodominance hierarchy in adult C57BL/6 mice has
been shown to strongly favor NP366-374 over PA224-233 (Crowe et al., 2003), and our data
correlates well with this. Mice first infected as adults demonstrated high levels of NP366374-specific

CD8+ T cells in whole-lung digest that arose around day 5 of infection and

persisted through day 10 of infection (Figure 3.3 A). In contrast, levels of PA224-233specific cells remained easily detectable throughout the infection but never rose
significantly above starting levels (Figure 3.3 B). Mice first infected as pups also
demonstrated clear populations of NP366-374-specific CD8+ T cells, but they arose around
day 7 of infection instead of day 5 (Figure 3.3 A). Unlike the mice first infected as adults,
mice first infected as pups developed appreciable populations of PA224-233-specific CD8+
T cells (Figure 3.3 B). These cells also arose around day 7 of infection. These data
suggest that primary influenza virus infection as a neonate alters the specificity and
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kinetics of secondary influenza virus challenges in comparison to primary and secondary
influenza virus infections in adults.
3.2.3

Adoptive transfer of bone marrow-derived dendritic cells alters CD8+ T cell
immunodominance during influenza virus infection and improves influenza virus
clearance in pups
Poor activation by neonatal dendritic cells has been implicated in many of the

altered T cell responses observed in neonates (Malloy et al., 2017; Ruckwardt et al.,
2014; Ruckwardt et al., 2018). We transferred BMDCs stimulated with LPS and
incubated with influenza virus or HBSS into 2-day-old pups before infecting them with
an LD10 dose of influenza virus. At day 3, 5 and 7 post-infection, similar numbers of
CD4+ T cells (Figure 3.4 A) as well as activated (CD44hi CD62L lo) CD4+ T cells
(Figure 3.4 B) were found in the lung digests of mice that received either treatment.
Similar results were found for CD8+ T cell populations (Figure 3.4 C, D). Both
treatments were associated with similar proportions of IFNγ-producing CD8+ T cells in
the lung digest at days 7 and 10 post-infection (Figure 3.4 E).
Despite these similarities in the overall magnitude of the response, transfer of PR8infected BMDCs alters the appearance of antigen-specific CD8+ T cell populations in the
lungs. Significantly more NP366-374 and PA224-233-specific CD8+ T cells were detected at
day 7 post-infection in pups that received PR8 infected BMDCs than pups that received
control BMDCs (Figure 3.5 A). By day 10 post-infection, NP366-374 and PA224-233-specific
CD8+ T cells were easily detectable in both treatment groups (Figure 3.5 A). Finally and
most intriguingly, pups that received PR8 infected BMDCs cleared the virus by day 10 of
infection while those that received control BMDCs did not (Figure 3.5 B). These data
suggest that providing adult-like dendritic cell activation to pups allows them to respond
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to NP366-374 and that influenza virus-loaded dendritic cells improve viral clearance in
pups.

3.3

Discussion
CD8+ immunodominance during PR8 infections in adult C57Bl/6 mice is stable and

predictable with NP366-374 and PA224-233 as clearly dominant epitopes during primary
infections (Belz et al., 2000). Recent work, however, suggests that established
immunodominance hierarchies may not hold in neonatal infections (Carey et al., 2016;
Ruckwardt et al., 2011). If neonates cannot be guaranteed to mirror adult hierarchies,
then the patterns of neonatal immunodominance and the means to manipulate neonatal
immunodominance must be understood on their own terms. Subunit and peptide
vaccines require predictable immunodominance hierarchies, and if infants do not respond
to the same subunits as adults, then subunit T cell vaccines could be ineffective for this
vulnerable population.
In our study, we found that neonatal C57BL/6 mice did not respond to the adult
dominant CD8+ T cell epitope of NP366-374 during primary PR8 infections. Instead, pups
responded to the PA224-233 epitope (Figure 3.1). Heterosubtypic challenges in mice
infected as pups or as adults displayed altered CD8+ T cell response timing and
immunodominance (Figure 3.3) that correlated with increased morbidity in mice first
infected as pups (Figure 3.2). Transfer of adult BMDCs partially shifted the neonatal
CD8+ response to a more adult-like immunodominance hierarchy, with PR8 infected
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BMDCs providing an earlier expansion of PR8-specific CD8+ T cells and improved viral
clearance when compared with mice that received unloaded BMDCs (Figure 3.5).
Effective clearance of viral pathogens, including influenza virus, requires antigenspecific CD8+ T cells (Graham et al., 1994). We have previously shown that neonates
display reduced homing of T cells to the lungs and airways during influenza virus
infection (Lines et al., 2010). Neonates are able to clear low levels of influenza virus,
although they do so much less effectively than adults (Lines et al., 2010). While CD8+ T
cells certainly play a major role in adult infections, it is unclear how significant their
contribution is to the limited neonatal anti-viral response. C57BL/6 pups do not
recognize the immunodominant adult CD8+ T cell epitope NP366-374. This deficit is clear
in both the lung parenchyma and the airspaces (Figure 3.1 B-D). A recent study suggests
that MHC-peptide tetramers can underestimate true antigen-specific cell populations,
especially for low-affinity T cells such as tumor infiltrating lymphocytes or autoreactive
T cells (Rius et al., 2018). It is possible that the lack of tetramer staining in neonatal lung
digest and BAL is due to low-affinity anti-NP366-374 cells instead of an absence of those
cells.
Neonatal T cells are hyporesponsive in vivo, with poor IFNɣ production and
proliferation (Basha et al., 2014; Graham et al., 1994; You et al., 2008). With proper
stimulation, however, they are able to respond more robustly (Adkins et al., 1994). When
a previous student cultured CD8+ T cells from pups and adults with bone marrow derived
dendritic cells (BMDCs) we saw that PR8 was able to provoke a strong IFNɣ response
comparable to that produced by adult CD8+ T cells (Lines, 2010). Conversely, NP366-374
loaded BMDC stimulation was not enough to promote an adult level response to NP366-
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374,

supporting the idea that the CD8+ population in pups simply lacks adult levels of

NP366-374-specific cells (Figure 3.1 A).
There is some controversy as to whether pups lack NP366-374-specific CD8+ T cells
in primary infections with one study suggesting a diminished response in pups infected
on day 3 or 7 of life (Carey et al., 2016), and another suggesting that pups respond to
NP366-374 at similar levels as adults (Zens et al., 2017). The chief difference between
these studies was the age of the pups with 2-week-old pups responding to NP366-374, 7day-old pups, responding minimally, and the 3-day-old pups that, like the 2-day-old pups
in this study, generally lacked NP366-374-specific CD8+ T cells altogether. This paints a
picture of a rapidly evolving CD8+ response with different immunodominance hierarchies
at different ages. Two-week-old pups are still immunologically immature in other ways,
but perhaps the altered immunodominance we observed is a feature only of the early
neonatal period.
While NP366-374 is the dominant CD8+ epitope in adult infections, other epitopes
such as PA224-233 also generate detectable responses in adult primary infections (Cukalac
et al., 2014). We looked to these subdominant epitopes to find potential targets for
neonatal T cells. We found that pups display robust PA224-233-specific populations
visible through tetramer analysis of pup whole-lung digest and BAL (Figure 3.1 B-E). In
pups, PA224-233-specific cells make up a similar proportion of total CD8+ T cells in pup
and adult lungs, suggesting that this is a major population in neonatal anti-influenza virus
responses (Figure 3.1 F). Neonates typically display few lymphocytes in the alveolar
spaces during influenza virus infection, as we have previously shown (Lines et al., 2010),
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but a large percentage of what CD8+ T cells are there are PA224-233-specific (Figure 3.1 G,
I).
Altered immunodominance in primary infections has important implications for
vaccination. There is currently a significant effort in developing a universal influenza
virus vaccine which is likely to rely on a subunit or peptide antigen (Estrada et al.,
2019). We were concerned that altered immunodominance in neonates could cause
problems when using these kinds of vaccines in young populations. Studies on herpes
simplex virus 1 (HSV-1) have suggested that neonatal infections can “lock in”
suboptimal immunodominance hierarchies for subsequent adult infections (Rudd et al.,
2013). Additionally, it has been demonstrated in influenza virus infections that T cell
memory from neonatal infections is less robust than memory from adult infections
(Connors et al., 2018; Zens et al., 2017). In our model, the memory from a pup primary
infection is clearly protective, as the animals survived an infection that was lethal to
naïve animals (Figure 3.2 A), but differences in the responses still exist and may explain
the relatively more severe disease course experienced by mice first infected as pups.
Mice first infected as adults show the previously described (Chen et al., 2004a;
Crowe et al., 2003) strongly NP366-374 dominant secondary response. Many of the mice
first infected as pups also have a strong NP366-374 response, however, the pattern was less
predictable than in mice first infected as adults (Figure 3.3 A). A few of the animals first
infected as pups were even PA224-233 dominant in the secondary response, maintaining the
neonatal immunodominance pattern (Figure 3.3 B). It has been suggested that a
predominately PA224-233-specific response might be detrimental in secondary infections
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(Crowe et al., 2003), but we did not have enough PA224-233 dominant animals to observe
this effect.
Intriguingly, although both groups displayed similar levels of total NP366-374 and
PA224-233-specific CD8+ T cells by day 7 of infection, there was an earlier onset of NP366374-specific

expansion in the mice first infected as adults (Figure 3.3 A).

Given that neonates seemed capable of responding to NP366-374 in a few individual
animals, we wanted to find a way to force a more consistent NP366-374-specific response in
pups. For this we turned to dendritic cells. Neonatal dendritic cells have been shown to
be much less stimulatory than adult dendritic cells in vivo due to a number of factors
including lower expression of costimulatory molecules and MHC class I and II
(Ruckwardt et al., 2014). Studies of respiratory syncytial virus (RSV) infection in pups
suggest that there are several populations of dendritic cells in the lungs of pups early in
life. They found that one of these phenotypes, a CD103+ population, was partially
responsible for the altered neonatal hierarchy observed in RSV infected pups (Malloy et
al., 2017; Ruckwardt et al., 2018). We reasoned that in influenza virus infections, adult
bone marrow-derived dendritic cells (BMDCs) might make pups respond more like
adults, immunodominance hierarchy included.
Pups that received BMDCs developed an NP366-374-specific population, whether or
not the dendritic cells were loaded with PR8, supporting the idea that neonatal dendritic
cells may be responsible for the pups’ altered hierarchy (Malloy et al., 2017; Ruckwardt
et al., 2018). It is not surprising that both unloaded and PR8 loaded BMDCs could
promote NP366-374-specific CD8+ T cell expansion, as unloaded BMDCs will also likely
take up PR8 during an infection. However, while both BMDC treatments promoted
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NP366-374-specific CD8+ populations at the peak of infection, PR8 loaded BMDCs did
improve the time needed to clear the virus (Figure 3.5 B). This correlates with an
increase in total NP366-374 and PA224-233-specific CD8+ T cells at day 7 post-infection
(Figure 3.5 A). Given that there were not differences in total CD4+ or CD8+ T cells,
activation status of those cells or IFNɣ production, we suspect that this altered onset of
antigen-specific CD8+ T cell expansion may be an important factor in explaining the
improved viral clearance PR8 loaded BMDCs provide (Figure 3.4). If NP366-374-specific
cells are more effective for enacting influenza viral clearance in pups as they are in adults
(Crowe et al., 2005), then it is possible that it is the early onset of NP366-374-specific cells
rather than total NP366-374 and PA224-233-specific cells that improves viral clearance in
these animals. Chapter 4 will address this question.
These data could contrast with the idea that neonates do not respond to NP366-374
due to the neonates’ immature TCR repertoires (Zens et al., 2017), but perhaps both
concepts could be important factors in establishing the altered neonatal
immunodominance hierarchy. Adult-like antigen presentation from BMDCs stimulated
NP366-374-specific CD8+ T cells in the pups, but not to the clearly NP366-374-dominant
levels observed in adult infections. It is possible that this remaining difference is due to
the immature TCR repertoire.
In conclusion, these data show a consistent shift in neonatal C57BL/6 CD8+ T cell
immunodominance during PR8 infection that influences but does not guarantee the
hierarchy of secondary infections. Additionally, this altered hierarchy can be
manipulated by altering the quality of dendritic cell activation available to neonatal CD8+
T cells, such as provided by BMDCs. These data suggest that age should be considered

70

when designing subunit vaccines for infants, but that with proper stimulation, it may be
possible to guarantee a response to the same targets in neonates and adults. Manipulating
neonatal immune responses requires a delicate touch. Adult magnitude responses are
effective for clearing many pathogens, but neonates frequently cannot tolerate the
immunopathology that accompanies such robust responses (Harbeson, Ben-Othman, et
al., 2018; Harbeson, Francis, et al., 2018). Improving infection outcomes in neonates will
necessitate highly specific interventions such as expanding virus-specific T cell
populations while avoiding more global T cell activation. We believe that neonatal
dendritic cells are a promising target for accomplishing this goal.
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Figure 3.1 Pups display PA224-233 dominance rather than the adult NP366-374 and PA224-233
codominance.
Adult or 2-day-old mice were infected i.n. with an LD10 dose of the PR8 strain of
influenza virus. At day 10 post-infection, TBLNs were obtained from infected mice and
cells were co-cultured with peptides and BMDCs. At day 3, supernatants were taken and
IFNγ concentration was measured by ELISA (A). Cells from whole-lung digest, as well
as bronchial alveolar lavage (BAL), were also obtained at day 10 post-infection and
stained with anti-CD8+ antibody as well as H-2D(b) NP366-374 and H-2D(b) PA224-233
tetramers. Representative scatter plots gated on CD8+ cells are shown for cells from
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adult lung (B) and BAL (C) as well as pup lung digest (D) and BAL (E). Data is
summarized as the percent of lung CD8+ T cells that are also tetramer positive in the lung
digest (F) and BAL (G). Total numbers of tetramer-positive CD8+ T cells are also shown
for lung digest (H) and BAL (I). Data show mean ± SD for two separate experiments
with at least 8 mice per group. * P <0.05 by student’s T test.
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Figure 3.2 Mice infected as pups lose more weight and display altered T cell responses
compared to mice infected as adults.
Adult or 2-day-old C57BL/6 mice were infected i.n. with an LD10 dose of the X-31 strain
of influenza virus before being infected again with an LD100 dose of the PR8 strain of
influenza virus 8 weeks later. Average percent of starting body weight is shown for the
secondary infection (A). Total numbers of CD4+ and CD8+ lymphocytes that were also
IFNᵧ+ are shown for the BAL at day 7 post-infection (B). Total CD4+ (C) and CD8+ (D)
lymphocytes in the lung digest were assessed by flow cytometry. Data show mean ± SD
for two separate experiments with at least 5 mice per group. * p< 0.05 compared to mice
first infected as pups at the same time point by one way or Kruskal-Wallis one-way
ANOVA on ranks followed by Dunn’s pairwise post-hoc test.
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Figure 3.3 Mice infected as pups display altered CD8+ T cell responses compared to mice
infected as adults during secondary infections.
Adult or 2-day-old C57BL/6 mice were infected i.n. with an LD10 dose of the X-31 strain
of influenza virus before being infected again with an LD100 dose of the PR8 strain of
influenza virus 8 weeks later. Lung digests were acquired at day 3, 5, 7 and 10 of
infection and stained with anti-CD8+ antibody as well as H-2D(b) NP366-374 and H-2D(b)
PA224-233 tetramers. Percent NP tetramer+ (A) or PA tetramer+ (B) of CD8+ T cells in the
lung digest was determined by flow cytometry. Data show individual mice and mean for
pooled data from two separate experiments with at least 4 mice per group. # p<0.05
compared to mice in the same group at day 3 of infection by one way ANOVA followed
by Holm-Sidak post-hoc test for pairwise comparisons.
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Figure 3.4 Adoptive transfer of PR8 infected BMDCs minimally effects overall T cell
responses during influenza virus infection.
BMDCs were generated from C57Bl/6 adult female mice and treated with LPS before
incubation with the PR8 strain of influenza virus or HBSS. Two-day-old C57BL/6 mice
were injected with 104 BMDCs before being infected i.n. with an LD10 dose of the PR8
strain of influenza virus. Total CD4+ (A), total activated (CD44+ CD62Llo) CD4+ T cells
(B), total CD8+ (C), and total activated (CD44+ CD62Llo) CD8+ T cells (D) were assessed
by flow cytometry in the lungs of infected pups on day 3, 5 and 7 post-infection.
Proportion of CD8+ T cells that were also IFNᵧ+ was assessed by flow cytometry on day 7
and 10 post-infection (E). Data show mean ± SD for two separate experiments with at
least 5 mice per group at each time point.
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Figure 3.5 Adoptive transfer of PR8 infected BMDCs improves viral clearance and alters
immunodominance during neonatal influenza virus infection.
BMDCs were generated from C57Bl/6 adult female mice and treated with LPS before
incubation with the PR8 strain of influenza virus or HBSS. Two-day-old C57BL/6 mice
were injected with 104 BMDCs before being infected i.n. with an LD10 dose of the PR8
strain of influenza virus. Total CD8+ T cells that were NP or PA tetramer+ in the BAL
was assessed by flow cytometry on day 7 and 10 post-infection (A). Viral burden at day
10 post-infection was assessed by plaque assay (B). Data show individual mice and mean
or mean ± SD for two separate experiments with at least 6 mice per group. Panel B used
with permission of Samantha Jewell. * p< 0.05 by student’s T test.
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CHAPTER 4. PEPTIDE VACCINATION WITH PA224-233 DOES NOT PROTECT PUPS
DURING INFLUENZA VIRUS INFECTION
4.1

Introduction
Vaccinating infants is one of the most important early life health interventions in

neonatal care (Rao et al., 2019). Vaccine schedules have been developed to optimize the
intersection of the developing neonatal immune system with the observed outcomes of
specific vaccines to maximize protection for infants as early in life as possible (Robinson
et al., 2019). Unfortunately, effective responses to some vaccines require infants to be 6
months old or even a year old before protective immunity can be established, leaving a
window of vulnerability to these diseases (Grohskopf et al., 2018).
Influenza virus is a significant cause of neonatal respiratory disease, and although
a vaccine exists for this virus, it cannot be administered before 6 months of age
(Antonova et al., 2012; Nelson et al., 2014; Neuzil et al., 2002). Additionally, it requires
two injections for full protection as opposed to the one injection adults require
(Grohskopf et al., 2018). On top of this, influenza virus vaccination is required yearly
due to viral antigenic drift and even these efforts only result in protection rates
approaching 60% on the most successful years (Doyle et al., 2019; Reed et al., 2015;
Thommes et al., 2017).
Significant effort is devoted to trying to increase the protection of influenza virus
vaccination by generating responses that are cross-reactive against more than one virus
strain (Estrada et al., 2019; Gottlieb et al., 2014; Xiang et al., 2015). These methods
stimulate B or T cell responses that target conserved regions of the virus such as the stalk
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region of the influenza virus surface protein HA or conserved regions of internal
components like NP (Krammer et al., 2019). Conserved regions of viral proteins
typically cannot mutate readily without decreasing viral fitness, so it is difficult for
viruses to escape immune responses to these epitopes (Kosik et al., 2019). Broadly
neutralizing antibodies are generated by a small subset of influenza virus infected
humans, and work is being done to replicate this phenomenon reliably in a vaccination
setting (Morgan et al., 2016; van Doorn et al., 2017).
CD8+ T cells are also the target of vaccination efforts for pathogens like influenza
viruses. These vaccines are often considered in conjunction with B cell responses rather
than as a standalone vaccine (Laidlaw et al., 2013; Lee et al., 2019). Studies of influenza
disease severity in humans suggests that CD8+ memory confers cross-reactive protection
against severe morbidity and mortality but not the complete neutralizing protection
antibody mediated vaccines provide against a single strain of influenza virus (Sridhar et
al., 2013). This still leaves CD8+ vaccination as a potentially important mechanism of
reducing disease severity with protection that is resistant to antigenic drift. Reduced
morbidity during influenza virus infection improves wellbeing among normal adult
populations, but among vulnerable populations such as infants and the elderly, the
difference in severity might significantly alter mortality risk.
If vaccines targeting CD8+ T cells are added to conventional influenza vaccine
strategies, it is important to ascertain whether they will function the same in neonates as
in adults. Neonates have well-documented alterations in T cell function compared to
adults. These include reduced numbers and infiltration into infected tissue, diminished
cytotoxicity, and reduced cytokine production. We have also shown along with others
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that neonates demonstrate an altered CD8+ T cell immunodominance hierarchy (Cukalac
et al., 2014; Malloy et al., 2017; Ruckwardt et al., 2011). These factors raise concerns
for whether a CD8+ T cell vaccine would work in neonates, especially if viral subunits
are chosen for T cell stimulation that neonates cannot respond to.
In this study we show that pups can respond to the influenza virus peptide PA224233

delivered by adult bone marrow derived dendritic cells (BMDCs), but not to NP366-374.

This vaccine results in a PA224-233-specific memory response during reinfection without
significantly altering the overall level of inflammation. PA224-233 vaccinated pups,
however, are not protected during lethal influenza virus challenge. Pup lung tissue is able
to stimulate adult NP366-374 and PA224-233-specific CD8+ T cells. These data suggest that
age is an important factor when considering targets for subunit vaccines targeting CD8+ T
cells.

4.2
4.2.1

Results
BMDC-peptide vaccination in pups generates PA224-233 but not NP366-374-specific
CD8+ T cells.
The neonatal CD8+ immunodominance hierarchy is altered compared to the adult

hierarchy in mice across several different infections (Malloy et al., 2017) including
influenza virus infection. We wanted to test whether neonatal mice could respond to
adult dominant epitopes when vaccinated with bone marrow derived dendritic cells
(BMDCs) loaded with peptide. We incubated BMDCs generated from adult C57BL/6
bone marrow with both PA224-233 and NP366-374 or with each peptide separately. We then
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injected peptide loaded-BMDCs I.P. into 2 day old pups or 8 week old adults and
examined antigen specific cells in the spleen by flow cytometry 14 days after vaccination.
Pups vaccinated with both peptides responded to PA224-233, but not NP366-374 (Figure 4.1
A). When pups were vaccinated with each peptide separately, the animals also responded
to PA224-233, but not NP366-374 (Figure 4.1 B). Adults vaccinated with both peptides and
CpG responded strongly to PA224-233. NP366-374-specific cells were present in vaccinated
adults, but only at low levels (Figure 4.1 C). Adults vaccinated separately with BMDCs
pulsed with NP366-374 or PA224-233 responded to the peptide they received (Figure 4.1 D).
These data suggest that unlike adults, pups cannot respond to NP366-374 by BMDC
vaccination.

4.2.2

Pups vaccinated with peptide loaded BMDCs display memory responses to PA224233 but not NP366-374.
Influenza virus specific memory CD8+ T cell responses protect against subsequent

infections resulting in reduced morbidity and mortality. To test whether peptide
vaccinated pups would display a memory response upon viral challenge, we vaccinated 2
day old pups with PA224-233 or NP366-374 loaded BMDCs as described before. Fourteen
days post vaccination, we infected the mice with an LD10 dose of PR8 influenza virus and
assessed the response in the whole lung digest, bronchioalveolar lavage, and the
tracheobronchial lymph node 7 days after infection. Reinfection at 14 days post infection
was chosen to ensure that the mice were still less than 3 weeks of age at reinfection. Pups
vaccinated with PA224-233 displayed elevated levels of PA224-233-specific CD8+ T cells in
the whole lung digest compared to unvaccinated or NP366-374 vaccinated pups, but NP36682

374

vaccinated pups did not display elevated NP366-374-specific CD8+ T cells compared to

unvaccinated or PA224-233 vaccinated pups (Figure 4.2 A). There were not significant
differences between PA224-233 or NP366-374-specific CD8+ T cell populations in the TBLN
(Figure 4.2 B). Vaccinated and unvaccinated pups displayed similar concentrations of
IFNγ in the BAL regardless of the peptide used (Figure 4.2 C). Additionally, vaccination
did not impact the proportion of CD4+ or CD8+ T cells that were activated (CD44+
CD62Llo) (Figure 4.2 D). Vaccinated animals had higher proportions (Figure 4.2 E) and
total numbers (Figure 4.2 F) of IFNγ producing CD8+ T cells than unvaccinated animals
and PA224-233 vaccinated pups had higher proportions of IFNγ producing CD4+ T cells
than unvaccinated animals (Figure 4.2 E). These data suggest that PA224-233 vaccination
results in a robust PA224-233-specific memory response in pups.

4.2.3

PA224-233 peptide vaccination does not provide protection during lethal challenge
in neonatal mice.
Effective CD8+ memory can offer protection from infectious doses that would be

lethal for naïve animals, but simply producing antigen specific T cells does not guarantee
effective protection. We wanted to determine whether PA224-233 vaccinated pups were
protected during lethal challenge. We vaccinated 2 day old pups with peptide loaded
BMDCs by i.p. injection. Fourteen days post vaccination, vaccinated and naïve mice
were infected with a lethal dose of influenza virus. All mice lost weight (Figure 4.3 A),
and neither vaccinated nor naïve animals survived the infection (Figure 4.3 B). These
data suggest PA224-233 vaccination offers no protection to pups during PR8 infection.
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4.2.4

Pup lung tissue is able to stimulate both NP366-374 and PA224-233 specific CD8+ T
cells.
Although peptide loaded BMDCs were unable to stimulate pup responses specific

for NP366-374, future vaccination methods may be able to stimulate reliable responses to
adult antigens in neonates. We wanted to test whether neonatal lung tissue could
stimulate NP366-374 specific CD8+ memory T cells. We infected adult C57Bl/6 mice with
PR8 influenza and isolated splenic CD8+ T cells by MACS cell separation at day 8 of
infection. Adult T cells were co-cultured with lung digest from naïve pups or adults or
BMDCs and either NP366-374 or PA224-233 peptide. Supernatants were collected at day 3 of
culture and IFNγ concentration was measured by ELISA. Pup lung tissue stimulated both
NP366-374 and PA224-233-specific adult CD8+ T cells (Figure 4.4 A). BMDCs also
stimulated both NP366-374 and PA224-233-specific CD8+ T cells. These data suggest that pup
lungs are able to stimulate an IFNγ response from NP366-374 specific CD8+ T cells if they
are generated during an immune response.

4.3

Discussion
Subunit vaccines rely on immunodominance to predict likely antigens that will

provoke effective B or T cell responses across a population (Crowe et al., 2005). Work
done characterizing adult CD8+ T cell responses to influenza virus has shown that adult
C57Bl/6 mice respond to NP366-374 and PA224-233 during primary PR8 infection (Belz et
al., 2000). We have shown that pups respond to PA224-233 but not NP366-374. Although
these specific peptides primarily relate to this particular mouse infection, altered
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immunodominance in neonatal CD8+ T cell responses has been seen in other infections as
well, suggesting this is a general feature of T cell responses in early life (Ruckwardt et
al., 2011). Altered immunodominance in neonates could prevent neonates from
responding to subunit vaccines targeting known adult-dominant epitopes. A potential
solution for shifted immunodominance is simply to target age appropriate antigens for
vaccines used in neonatal or adult populations. The success of this strategy relies on two
things. First, neonates must be able to respond to a chosen antigen, and secondly, the
response to that antigen must be protective.
We found that mouse pups respond to PA224-233 but not NP366-374 vaccination using
peptide loaded BMDCs (Figure 4.1). PA224-233 vaccinated pups also display a robust
PA224-233-specific CD8+ T cell response during influenza virus challenge, although overall
T cell responses were not significantly elevated (Figure 4.2). Despite PA224-233-specific
memory, vaccinated pups were not protected from lethal challenge (Figure 4.3). Finally,
pup lung tissue was able to activate adult NP366-374-specific CD8+ T cells (Figure 4.4).
We wanted to establish whether pups could be vaccinated with both NP366-374 and
PA224-233. Pilot studies with both peptides and CpG as an adjuvant in adult vaccinations
showed strong PA dominance, although some NP366-374-specific cells were present
(Figure 4.1 C). This is consistent with previous studies that showed that PA224-233 is
strongly dominant over NP366-374 when antigen quantities are similar. Adult PA224-233specific cells have higher affinity than adult NP366-374-specific cells which possibly allows
them to become dominant when antigen is not limited (Cukalac et al., 2014). In an
influenza virion, the quantity of NP far surpasses the quantity of PA224-233 (Zheng et al.,
2013), suggesting that in a natural infection, antigen availability is possibly not the same
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for NP and PA, allowing NP366-374 to become co-dominant. This may be particularly true
in dendritic cells, as no viable viral replication occurs and the quantity of antigen in the
actual virion may represent the antigen available for presentation to T cells. Some NP
and HA synthesis occurs in DCs providing further evidence that NP may be available in
much greater quantities for presentation on DCs (Ioannidis et al., 2012) .
Pups responded only to PA224-233 when vaccinated with both peptides and BMDCs
(Figure 4.1 A). This is probably not due to suppression of a NP366-374 response by the
PA224-233 response as pups also did not respond to NP366-374 when vaccinated with only
NP366-374 or PA224-233 (Figure 4.1 B). Adults vaccinated with only NP366-374 or PA224-233
responded well to whichever peptide they received (Figure 4.1 D). These data show that
even when delivered with adult BMDCs, pups do not respond to NP366-374 peptide.
The PA224-233 specific response exhibited by neonates expands appropriately
during subsequent challenge, suggesting that the peptide vaccine succeeds in establishing
CD8+ T cell memory in pups (Figure 4.2 A). NP366-374 vaccinated pups did not display
similar expansion of NP366-374-specific cells, confirming that there was no response to the
NP366-374 vaccine. Neither vaccine increased T cell activation significantly (Figure 4.2
D), but both vaccinated groups had more IFNγ producing cells than unvaccinated
animals. This was not different between NP366-374 and PA224-233 vaccination, suggesting
that this increase is not related to the expansion of PA224-233-specific cells in PA224-233
vaccinated pups. This is consistent with other work showing that pups respond in a more
Th1 manner when given adult dendritic cells (van Haren et al., 2016).
If pups can respond well to PA224-233, vaccinating with this peptide could provide
protection, even if they fail to respond to NP366-374. Adult studies have shown, however,
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that PA224-233-specific cells are not effective for anti-influenza viral defense. Adult mice
vaccinated against PA224-233 respond robustly, but they suffer greater morbidity and
mortality than even naïve animals (Crowe et al., 2005). Dendritic cells can present both
NP366-374 and PA224-233 equally well, as has been shown before (Crowe et al., 2003) and in
Figure 4.4 B. Respiratory epithelium, however, was shown to only present NP366-374
(Chen et al., 2004a). PA224-233-specific CD8+ T cells may be generated, but they may not
recognize and target infected respiratory epithelial cells.
In a normal adult infection, NP366-374 and PA224-233-specific cells are activated by
dendritic cells, but only NP366-374-specific cells are able to recognize and kill infected
cells. This seems to lead to more robust NP366-374-specific memory and NP366-374
dominance in secondary infection as secondary responses are thought to rely on infected
tissue rather than dendritic cells for activation and expansion (Crowe et al., 2003). We
saw this phenomenon clearly in our heterosubtypic infections (Figure 3.3). However,
when adults are vaccinated for PA224-233, the PA224-233-specific cells strongly dominate
during a challenge reaction and prevent an NP366-374 response (Crowe et al., 2005). This
lack of protection calls into doubt whether the PA224-233 specific CD8+ response exhibited
by pups provides any benefit during influenza virus infection.
We saw that PA224-233 vaccination provided no defense against lethal influenza
virus challenge in pups (Figure 4.3 B). Simply vaccinating against PA224-233 will not
resolve the problems with the neonatal CD8+ T cell response to PR8 influenza. This
agrees with findings that suggest neonatal primary infections can “lock in” suboptimal
memory cells for subsequent infections (Rudd et al., 2013).
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Finally, questions remain as to whether NP366-374 specific cells are effective in
pups. We saw that pup lung tissue was able to activate NP366-374-specific and PA224-233specific CD8+ T cells in vitro (Figure 4.4 A). This provides some evidence that pups
could utilize NP366-374-specific cells in the lungs if a vaccine manages to generate them,
but it does not show which cells are activating the T cells. Ideally, we would want to
check whether respiratory epithelial cells in pups present NP366-374 and PA224-233, but
given the lack of protection in PA224-233 vaccinated pups, it is likely that they follow the
adult NP366-374-only presentation pattern.
Given these results, we suggest that the goal of neonatal CD8+ T cell vaccination
should be to generate responses with adult specificity. Special consideration has been
given to neonatal immune responses before when designing vaccines such as the
development of conjugated vaccines that target polysaccharide antigens to protect against
Haemophilus influenza B and Neisseria meningitidis. Neonates respond poorly to
polysaccharide antigens without T cell help, so polysaccharide antigens were conjugated
to protein carriers to provide T cell as well as B cell stimulation (D'Angio et al., 1995).
Given that LPS stimulated PR8 infected BMDCs were able to generate an NP366-374
specific response in neonatal primary infections (Figure 3.5 F), we hoped this would
allow NP366-374 peptide vaccination in pups, but it was evidently not sufficient to
stimulate a NP366-374-specific response. There are many vaccination strategies and
adjuvants besides BMDCs loaded with peptide, and it is possible that one of these
methods will be able to stimulate an NP366-374-specific CD8+ T cell response in neonates.
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Figure 4.1 Pups respond to PA224-233 peptide but not NP366-374 peptide after BMDC
vaccination.
BMDCs were generated from C57Bl/6 adult female mice and treated with LPS before
incubation with NP366-374 and PA224-233 together or individually. 2 day old or adult mice
were injected i.p. with 104 or 105 BMDCs respectively. At day 14 post vaccination,
splenocytes were stained with anti-CD8+ antibody as well as H-2D(b) NP366-374 and H2D(b) PA224-233 tetramers. Tetramer+ cells were assessed in pups vaccinated with both
NP366-374 and PA224-233 simultaneously by flow cytometry (A). After separate NP366-374 or
PA224-233 vaccination, NP+ cells in NP366-374 vaccinated pups and PA+ cells in PA224-233
vaccinated pups (B) and adults (D) were assessed by flow cytometry at 14 days post
vaccination. Tetramer+ cells in adults vaccinated with NP366-374 and PA224-233 together
was assessed by flow cytometry (C). Data show mean ± SD for two separate experiments
with at least 4 mice per group. * p< 0.05 by student’s T test.
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Figure 4.2 PA224-233 vaccinated pups develop a PA224-233-specific memory response when
challenged with PR8 Influenza virus.
2 day old mice were injected i.p. with 104 BMDCs pulsed with NP366-374 or PA224-233 and
then infected 14 days later with a LD10 dose of the PR8 strain of influenza virus. The
percent NP or PA tetramer+ of CD8+ lymphocytes in the lung digest (A) and TBLN (B) at
day 7 post infection was determined by flow cytometry. IFNγ was measured in the first
wash of the BAL from day 7 post infection by ELISA (C). Percent activation (CD44hi
CD62Llo) of CD4+ and CD8+ lymphocytes on day 7 post infection was determined by
flow cytometry (D). Proportion (E) and total numbers of CD4+ and CD8+ lymphocytes
that are IFNγ+ on day 7 post infection were determined by flow cytometry. Data show
mean ± SD for two separate experiments with at least 4 mice per group. * p< 0.05 by one
way ANOVA followed by Holm-Sidak post-hoc test for pairwise comparisons.
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Figure 4.3 PA224-233 peptide vaccination does not protect neonates during lethal infection.
2 day old mice were injected i.p. with 104 BMDCs pulsed with NP366-374 or PA224-233 and
then infected i.n. 14 days later with an lethal dose of the PR8 strain of influenza virus.
Mice were weighed daily (A). Pup survival was also determined daily (B). Weight data
show mean ± SEM for two separate experiments with at least 4 mice per group. NS, Not
significant by one way ANOVA followed by Holm-Sidak post-hoc test for pairwise
comparisons.
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Figure 4.4 Pup lung tissue activates NP366-374 and PA224-233-specific adult memory CD8+
T cells.
8 week old mice were infected with a LD10 dose of the PR8 strain of influenza virus and
CD8+ T cells were isolated from spleens on day 8 of infection. Lung digest from naïve 2
day old or adult mice (A) or BMDCs (B) were co-cultured with CD8+ T cells and NP366374

or PA224-233 peptides. Supernatants were collected on day 3 and IFNγ concentration

was assessed by ELISA. Data represent mean ± SD (A) or SEM (B) for two separate
experiments. n=4 mice per group (A) or 3 replicate wells (B).
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CHAPTER 5. REGULATORY T CELLS DURING NEONATAL INFLUENZA VIRUS
INFECTION.
5.1

Introduction
Immunopathology is a necessary consequence of immune responses that kill

pathogens, but one that can be devastating to vulnerable populations such as neonates
(Merkus, 2003). It has been proposed before that disease tolerance is an alternate
strategy organisms may take to survive pathogen exposures (Medzhitov et al., 2012).
The balance between response and tolerance to both pathogens and innocuous antigens is
strongly skewed towards tolerance in neonates. This has been demonstrated in neonates’
skewed T cell responses towards Th2 responses instead of Th1 (Adkins et al., 2002) as
well as broad delays in activation and migration across multiple other cell types in
response to infection (Lines et al., 2010). This results in increased susceptibility to many
illnesses for neonates, but it is likely that the benefit of avoiding severe
immunopathology is worth the weakened defense against pathogens.
Regulatory T cells (Tregs) are an important mediator of host tolerance both to
self-antigens as well as pathogens. This is clearly demonstrated in scurfy mutant mice
which lack Tregs due to a nonsense mutation in Foxp3, the master regulator transcription
factor of Treg development. Scurfy mice develop massive autoimmunity and die by three
weeks of age (Godfrey et al., 1991). Tregs suppress immune responses through a variety
of mechanisms including expression of suppressive cytokines like TGFβ and IL-10. They
also express high levels of CD25, the high affinity IL-2 receptor, allowing them to take
up IL-2 and deny it to other T cells, limiting their growth (Vignali et al., 2008).
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Tregs likely play a key role in neonatal immunosuppression. Tregs are crucial in
protecting the fetus from maternal rejection during gestation (Michaelsson et al., 2006),
and Treg levels remain high after birth (Hamza et al., 2015; Oliphant et al., 2015;
Scharschmidt et al., 2015). Neonates also have a mechanism that promotes Treg
differentiation as a sort of “default” outcome of T cell activation (Cheng et al., 2014;
Wang et al., 2010).
Given that the bias towards tolerance diminishes neonatal defense against
pathogens, elevated Tregs in neonates could underlie early life vulnerability to infection.
Manipulating Tregs has been proposed as a way to augment immune responses; however
efforts to remove Tregs to improve infection outcomes have revealed a much more
complicated role for Tregs in infections of both adults and neonates than simple
immunosuppression. Treg depletion unquestionably increases immunopathology during
infection as expected (Lanteri et al., 2009; Lee et al., 2010; Suvas et al., 2004), but
pathogen clearance is improved in adult mice for a wide variety of infections including
tuberculosis (Scott-Browne et al., 2007), pneumocystis pneumonia (McKinley et al.,
2006), and Candida albicans (Pandiyan et al., 2011). Conversely, Tregs are necessary or
at least helpful for pathogen clearance in other adult infections including West Nile virus
(Graham et al., 2014), lymphocytic choriomeningitis virus (LCMV) (Lund et al., 2008),
and Citrobacter (Wang et al., 2014).
Little work has been done to characterize the role of Tregs in neonatal infections,
but just as in adults, Treg depletion or absence enhances pathogen clearance for some
infections and compromises it for others. Treg depletion magnifies neonatal responses to
HIV (Legrand et al., 2006), and HSV-2 (Fernandez et al., 2008a), but neonates can
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struggle to survive the increased inflammation produced by Treg depletion (Tucker et al.,
2013). Partially depleting Tregs in pups that over-express them improves viral clearance
(Jaligama et al., 2017), but we have previously shown that mouse pups without Tregs
have diminished influenza virus clearance (Oliphant et al., 2015). Intriguingly, Treg
depletion in adults during flu infection has been shown to result in diminished germinal
center formation and decreased antibody production (Leon et al., 2014) although this did
not alter the course of influenza infection in these animals (Betts et al., 2011). It is
possible that Tregs perform a unique function in neonates or that the role they play in
influenza viral defense is more essential in neonates.
Tbet and Gata3 are transcription factors associated with Th1 and Th2 CD4+ T cell
subsets, respectively, but they have functions beyond these cells. Tregs can express these
proteins transiently along with the Treg master regulator transcription factor Foxp3. In
Tregs, Tbet and Gata3 contribute to the maintenance of Treg function in inflammatory
environments where Tregs are at risk for downregulation of Foxp3 and loss of
suppressive function (Wohlfert et al., 2011). Tbet and Gata3 are partially redundant in
this role, as single Tbet or Gata3 Treg specific knockout mice do not develop broad
autoimmunity while double knockouts develop scurfy-like autoimmunity at around 6
weeks of life (Yu et al., 2015). While the role of Tbet and Gata3 is being studied in the
context of suppressive function in adults, their role in neonatal Tregs as well as their
potential role in neonatal influenza virus infections is unknown.
In this study we show that neonates lacking Tregs display compromised antibody
production during influenza virus infection. This correlates with diminished lymph node
size and a concurrent decrease in T follicular helper cells (Figure 5.1). We also show that
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a large proportion of neonatal Tregs express Gata3 compared to adult Tregs, especially
during influenza virus infection (Figure 5.2). Finally, we show that Treg specific Gata3
knockout pups are grossly abnormal (Figure 5.3), display elevated Tbet expression in
Tregs as well as conventional T cells during influenza infection (Figure 5.4), and suffer
increased morbidity during infection despite increased Tfh populations (Figure 5.5).

5.2
5.2.1

Results
Treg deficient mice have compromised influenza virus neutralizing antibody
production
We have previously shown that neonatal mice that lack Tregs cannot clear

influenza virus. Other studies have shown that Treg depleted adult mice have diminished
germinal center formation during influenza virus infection although this does not alter the
course of adult infection. We wanted to assess whether Treg deficient pups display
decreased antibody production as this could be responsible for the diminished antiinfluenza response observed in these animals. We infected 2 day old pups or adult mice
and harvested the tracheobronchial lymph node (TBLN) at day 10 post infection.
Infected pups and adults had more total CXCR5+ PD-1+ T follicular helper cells (Tfh)
than uninfected age-matched controls, but infected adults also had significantly more
Tfhs than infected pups (Figure 5.1 A). We then depleted Tregs from Foxp3DTR pups and
infected them with an LD10 dose of influenza virus. We evaluated the TBLN at day 10 of
infection by flow cytometry. Depleted pups had decreased proportions of CD4+ T cells,
CD19+ B cells, and Foxp3+ Tregs. The proportion of Tfh cells was not different between
depleted and undepleted pups (Figure 5.1 C). The TBLNs of depleted pups were much
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smaller than undepleted pups and this correlated with lower cell counts in depleted
animals. Depleted pups had fewer total CD4+ T cells, CD19+ B cells, Foxp3+ Tregs, and
Tfhs (Figure 5.1 D). We then infected scurfy pups and WT littermates with an LD10 dose
of influenza and collected serum at day 9 of infection to evaluate anti-influenza antibody
production by hemagglutinin inhibition assay. Scurfy pups had diminished antibody
production compared to WT littermates (Figure 5.1 E). As expected, Treg depleted
animals had elevated numbers of CD4+ T cells (Figure 5.1 F) and elevated IFNγ
producing CD4+ T cells in the lungs (Figure 5.1 G). These data suggest that loss of Tregs
significantly increases lung inflammation while diminishing effective TBLN responses
and compromising hemagglutinin neutralizing antibody production in pups.
5.2.2

Pup and adult Tregs express Tbet during influenza virus infection and Pup Tregs
express Gata3.
Tregs often display diverse functions in pathologic and steady state conditions

and may express different transcriptional programs depending on their environment. We
wanted to determine whether neonatal Tregs expressed conventional T cell transcription
factors Tbet and Gata3 during influenza virus infection. We infected 2 day old pups and
adults with an LD10 dose of influenza and evaluated Tbet, Gata3 and Foxp3 expression in
the whole lung digest at days 7, 11, and 14 post-infection (Figure 5.2 A-D). Few Tregs
express Tbet in uninfected pups or adults at early or late in the infection in infected
animals, but an elevated proportion of Foxp3+ cells co-express Tbet at day 11 of infection
in both pups and adults (Figure 5.2 E). Infected and uninfected pups display a higher
proportion of Tregs co-expressing Foxp3 and Gata3, especially during infection. Adult
Treg expression of Gata3 remains low in uninfected animals as well as during influenza
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virus infection (Figure 5.2 F). These data suggest that Gata3 is often expressed by pup
Tregs and Tbet is upregulated in Tregs during influenza virus infection.
5.2.3

Treg specific knockout of Gata3 results in small mice with no overt disease
Previous work has suggested that Gata3 performs a role in suppressive Treg

physiology by promoting the maintenance of Foxp3 expression in inflammatory
conditions. Given the high number of Gata3+ Tregs in neonates, we wanted to determine
whether Gata3 performs an important role in Treg function during influenza virus
infection. We generated Treg specific Gata3 knockout mice by crossing Foxp3cre mice
with mice expressing Gata3 flanked by loxp (Foxp3+Gata3-). Expression of Gata3 in
Foxp3+ cells is significantly diminished in these animals (Figure 5.3 A), but not littermate
controls (Figure 5.3 B). Foxp3+Gata3- animals are not phenotypically normal on gross
examination (Figure 5.3 C). They have small litters with a decreased proportion of
Foxp3+Gata3- pups (Figure 5.3 D) and Foxp3+Gata3- pups are substantially smaller than
littermate controls (Figure 5.3 E). These data suggest that Foxp3+Gata3- mice are viable
but that loss of Gata3 in Tregs reduces fitness substantially.
5.2.4

Treg specific Gata3 KO pups express higher levels of Tbet without an increase of
IFNγ producing cells
The precise effects of knocking out Gata3 in Tregs is debated, and the

consequences of this KO in pup anti-influenza virus immune responses has not been
established. We infected Foxp3+Gata3- pups and littermate controls with an LD10 dose of
influenza virus and evaluated lung digest and lymph node cell populations by flow
cytometry. Foxp3+Gata3- pups had a higher proportion of Foxp3+ cells in the TBLN
compared to littermate controls (Figure 5.4 A), although total numbers of Tregs did not
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differ between Foxp3+Gata3- and littermate control TBLNs (Figure 5.4 B). There was no
difference in proportion or total numbers of Foxp3+ CD4+ T cells in the lung digest of
Foxp3+Gata3- pups or littermate controls (Figure 5.4 C, D). Proportions of IFNγ
producing CD4+ T cells were higher in the lung digest of Foxp3+Gata3- pups (Figure 5.4
E), but proportions of IFNγ producing CD8+ T cells did not differ between lung digests
(Figure 5.4 F). Higher proportions of both Tregs (Figure 5.4 G) and conventional CD4+ T
cells (Figure 5.4 H) expressed Tbet in Foxp3+Gata3- pups. These data suggest that loss of
Gata3 in Tregs increases Tbet expression, and this shift is correlated with an increase of
IFNγ producing CD4+ T cells.
5.2.5

Foxp3+Gata3- pups have no significant decrease in hemagglutinin neutralizing
antibody, but suffer greater morbidity during infection than littermate controls
As Tregs are important for germinal center formation and antibody production

during influenza virus infection, we wanted to test whether Treg-specific Gata3 loss
would alter this function in pups. We infected Foxp3+Gata3- pups and littermates with an
LD10 dose of influenza virus and evaluated lymph node cell populations by flow
cytometry. Foxp3+Gata3- pups and littermates displayed similar proportions (Figure 5.5
A) and total numbers (Figure 5.5 B) of CD19+ cells in the TBLN at day 13 of infection.
Despite displaying normal levels of CD19+ cells, Treg Gata3 pups had lower influenza
virus neutralizing antibody titers in the serum compared with WT pups with a p value of
0.15 (Figure 5.5 C). Finally, Foxp3+Gata3- pups suffer greater morbidity than littermate
controls during influenza infection with weight loss late in the infection rather than just
the slowed growth WT pups experience when infected (Figure 5.5 D, E). These data
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suggest that Treg specific loss of Gata3 detrimentally influences the influenza disease
course in mouse pups, possibly by decreasing influenza neutralizing antibody production.

5.3

Discussion
Tregs clearly suppress pathogen-specific immune responses in pups and adults

(Fernandez et al., 2008a), but simply diminishing their function or removing some of
them is not a solution for improving outcomes, especially in neonates who manage the
increased inflammation that accompanies decreased Treg function poorly (Tucker et al.,
2013). So poorly, in fact, that performing experiments examining neonatal immunity
after Treg depletion is often challenging due to high pup mortality. We have shown that
neonatal mice lacking Tregs cannot clear influenza with the same kinetics as WT mice,
adding to the complex picture of Treg function during infections (Oliphant et al., 2015).
Determining the specific nature of these functions is of paramount importance for safely
manipulating anti-pathogen and vaccine responses.
In this study, we found that Treg depletion compromises influenza virus
neutralizing antibody production in pups (Figure 5.1). We also saw that a large
proportion of Tregs in pups co-expressed Gata3 and Foxp3 while both pups and adults
co-expressed Tbet and Foxp3 during infection (Figure 5.2). Treg specific knockout of
Gata3 produces abnormally small mice (Figure 5.3). We found that these mice have
altered Tbet expression but minimally altered T cell responses in their lungs (Figure 5.4).
Finally, we showed that Treg Gata3 KO pups experience greater morbidity during
influenza virus infection correlated with decreased influenza virus neutralizing antibody.
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Immune regulation is essential in both steady state and infection conditions, but
the nature of that regulation differs between adult and neonatal animals according to the
divergent needs of those phases. The ability to mount a protective response in neonates is
superseded by immunosuppressive programming, but partially effective antiviral
responses are still present in neonates (Harbeson, Ben-Othman, et al., 2018; Medzhitov et
al., 2012). This response conveys substantially reduced protection from influenza virus
infection compared to adult responses, but the limited functionality of the response leaves
pups vulnerable to perturbations of the system.
Other studies have shown that Tregs support germinal center formation and thus
high quality antibody production by taking up excess IL-2 that would otherwise inhibit
the generation of T follicular helper cells (Tfh) (Leon et al., 2014). Treg depletion was
not shown to have any effect on disease course in adults (Betts et al., 2011), suggesting
that the diminished antibody production did not compromise viral defense in these
animals. We showed that a similarly diminished Tfh response occurs after Treg depletion
in pups (Figure 5.1 C). However, pups already display a diminished Tfh response to
influenza virus compared to adults (Figure 5.1 A). Additionally, others have reported
that under normal circumstances pups have disordered germinal center formation and
decreased B-T cell interaction leading to lower production of high quality antibodies
during infection (Mastelic et al., 2012; Munguía-Fuentes et al., 2017). Decreasing the
already dangerously low lymph node response in pups may compromise antibody
production to a greater extent than in adults (Figure 5.1 D). This could explain the
inability of scurfy pups to clear influenza infection within the 14 days WT pups require to
clear.
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While Foxp3 is the defining transcription factor in Treg development and
function, conventional T cell transcription factors like Tbet and Gata3 are also expressed
by Tregs (Yu et al., 2015). These factors appear to perform a variety of roles in
supporting Treg function, especially in inflammatory conditions, but their role in neonatal
Tregs is unknown as is their role in promoting influenza virus defense. Expression of
Gata3 and Tbet is known to be volatile in Tregs, and we see that in neonatal Tregs during
influenza virus infection as well. Pup Tregs upregulate Tbet during infection which is
consistent with what has been reported with adult Tregs (Bedoya et al., 2013). Bedoya et
al (2013) associated Tbet expression with the development of adult influenza-specific
Tregs. These Tregs are partially responsible for restraining anti-viral immunity and
preventing extensive pathology. Given that pup CD4+ T cells are predisposed to
differentiate into Tregs upon antigen stimulation (Wang et al., 2010), it is likely that
many Tregs during influenza virus infection are influenza-specific. The elevated
proportion of Tbet+ Tregs during infection may represent these virus-specific cells in
pups as well as in adults (Figure 5.2 A).
Gata3 is thought to help Tregs maintain suppressive activity during inflammatory
conditions. Foxp3 expression is not stable and Tregs can de-differentiate if proper
stimulation is not maintained (Wohlfert et al., 2011). This is important for maintaining
the proper level of suppression at steady state and during inflammation as balance must
be maintained between the effectiveness of the response and potential pathology. We
found that a high proportion of Tregs in pups expressed Gata3 (Figure 5.2), compared to
adults, suggesting that this transcription factor may have a significant role in neonatal
Treg function.
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A simple explanation for the elevated Gata3 could be that Gata3 can be
upregulated in Tregs during IL-4 stimulation (Abdel Aziz et al., 2018). Given the Th2
bias in neonatal T cell responses and the elevated IL-4 produced during neonatal
influenza infection (Lines et al., 2010), the high expression of Gata3 in neonatal Tregs
may be driven by IL-4. Using IL-4 KO mice could help determine if this is an important
mechanism in promoting Gata3 expression in neonatal Tregs.
Global knock out of Gata3 is embryonic lethal, but cell specific Gata3 KO mice
are feasible. We generated Foxp3+Gata3- mice by crossing mice expressing Gata3
flanked by loxp with Foxp3 cre mice. This has been done before, and other groups report
that these mice are phenotypically normal or that they develop autoimmunity several
months into life (Wohlfert et al., 2011; Yu et al., 2015). Losing Gata3 does not totally
compromise Treg function, but one study reported that elimination of both Tbet and
Gata3 led to a scufy like phenotype in affected mice including multi-organ autoimmunity
and early death (Yu et al., 2015).
We saw that Foxp3+Gata3- mice were not phenotypically normal, with reduced
body mass compared to WT animals and difficulties breeding (Figure 5.3). Of our
breeding pairs, only Foxp3+Gata3- females successfully bred. Foxp3+Gata3- males
produced no offspring (data not shown). This was despite the small size of Foxp3+Gata3females. The poor breeding went beyond infrequent litters. By simple genetics, litters
should have been half Foxp3+Gata3- pups and half littermate controls, but we consistently
observed that fewer than 1 in 3 pups from any litter were Foxp3+Gata3- (Figure 5.3 D).
This could have been due to death shortly after birth, destruction by the mother, or
resorption in utero. Tregs are essential for maintaining tolerance to the fetus during
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pregnancy, and disruption of Treg function often results in loss of pups (La Rocca et al.,
2014). Regardless, other than these factors, the Foxp3+Gata3- mice showed no overt
signs of disease or development of autoimmunity during the course of these studies.
Others have reported that Treg specific deletion of Gata3 does not impair Treg
function, but they were assessing the ability of Foxp3+Gata3- Tregs to prevent colitis in
an adoptive transfer model (Yu et al., 2015). There is other evidence that Gata3 may play
a role in promoting Treg function specifically during inflammatory conditions (Abdel
Aziz et al., 2018; Wohlfert et al., 2011). Our findings suggest that loss of Gata3 does not
result in a total loss of suppressive function, but that does not mean there is no effect.
Infected Foxp3+Gata3- pups had higher proportions of Tbet+ conventional T cells and
Tregs (Figure 5.4 E, F). The higher proportion of Tbet expressing Tregs is not surprising
given that Gata3 expression suppresses Tbet expression under normal conditions
(Kanhere et al., 2012). The increase in conventional T cell Tbet expression, however,
indicates a possible loss of suppression and induction of a Th1 phenotype in CD4+ T
cells. IFNγ expression is increased in CD4+ T cells but not CD8+ T cells of Foxp3+Gata3mice suggesting that this increase in Tbet expression is promoting a Th1 phenotype in
Foxp3+Gata3- mice. Although this decrease is suppressive function during infection is
consistent with previous studies (Wohlfert et al., 2011), we did not see a defect in Treg
accumulation in the lungs (Figure 5.4 C, D). Wohlfert et al. (2011) examined Treg
accumulation during gut inflammation, so it is possible that Gata3 effects targeting to that
tissue but not the lung, or that Treg accumulation in inflamed tissues occurs through
different mechanisms in neonates.
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If Treg suppressive function is impacted by elimination of Gata3, it is likely that
pups will experience greater morbidity during infection. Indeed, Foxp3+Gata3- pups
suffered increased morbidity during infection than littermate controls, especially later in
infection. Foxp3+Gata3- pups actually lost weight for two days during the infection,
which typically only happens in severely ill pups (Figure 5.5 E). Small size may be a
contributing factor to the decreased weight gain experienced by KO pups, but we cannot
determine how much initial weight factored into morbidity.
Finally, Foxp3+Gata3- pups also had slightly diminished influenza neutralizing
antibody in their serum than littermate controls (Figure 5.5 C). This is not the severely
compromised antibody response seen in scurfy pups, but it may contribute to the increase
morbidity in Foxp3+Gata3- pups. Total numbers of TBLN B cells were not altered in
Foxp3+Gata3- pups (Figure 5.5 A, B), but this says nothing about the function of those
cells.
While Tregs do suppress neonatal immune reactions, they are certainly not purely
detrimental during influenza virus infection. Manipulating Treg function is a tempting
target for improving neonatal outcomes, but we have demonstrated that these cells are
likely required for optimal responses. More sophisticated manipulations might be able to
separate the suppressive and pro-immune functions of Tregs, but this must be done with
care.
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Figure 5.1 Loss of Tregs compromises anti-influenza virus antibody production.
2 day old or adult mice were infected i.n. with an LD10 dose of the PR8 strain of
influenza virus. TBLNs were collected at day 10 of infection and total numbers of Tfhs
were determined by flow cytometry (A). Tfhs were defined by expression of PD-1 and
CXCR5 (B). 2 day old Foxp3DTR mice were injected with 50μg/kg diphtheria toxin or
HBSS i.p. and then infected i.n. with an LD10 dose of the PR8 strain of influenza virus.
Proportion (C) and total numbers (D) of CD4+, CD19+, Foxp3+ and Tfh cells were
determined in the TBLN of infected animals at day 10 of infection. 2 day old scurfy and
WT littermates were infected i.n. with an LD10 dose of the PR8 strain of influenza virus
and serum was collected at day 10 of infection. Hemagglutinin neutralizing antibodies
were measured by hemagglutinin inhibition assay (E). Total lung CD4+ (F) and CD4+
IFNγ+ (G) T cells were assessed in scurfy mice by flow cytometry. Data show mean ± SD
for two separate experiments with at least 4 mice per group. * p< 0.05 by student’s T test
or one way ANOVA followed by Holm-Sidak post-hoc test for pairwise comparisons.
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Figure 5.2 Pup Tregs express Gata3 and both pup and adult Tregs express Tbet during
influenza virus infection.
2 day old or adult mice were infected i.n. with an LD10 dose of the PR8 strain of
influenza virus. Representative dot plots gated on CD4+ T cells are shown of Foxp3 and
Tbet (A) or Gata3 (B) expression at day 11 of infection in pups. Representative dot plots
are shown of Foxp3 and Tbet (C) and Gata3 (D) expression at day 11 of infection in
adults. Insets show isotype control. Proportion Tbet+ (E) or Gata3+ (F) of Foxp3+ CD4+
lymphocytes in the lung digest at days 7, 11, and 14 of infection was determined by flow
cytometry. Data show mean ± SD for two separate experiments with at least 6 mice per
group. * p<0.05 compared to uninfected animals. # p<0.05 compared to adult mice at the
same day. Significance calculated by one-way ANOVA followed by Holm-Sidak posthoc test for pairwise comparisons.
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Figure 5.3 Treg specific knock out of Gata3 results in small mice that breed poorly but
show no sign of overt disease.
Foxp3+Gata3- mice were generated by crossing mice expressing Gata3 flanked by loxp
with Foxp3cre mice. Proportion Gata3+ of Foxp3+ CD4+ lymphocytes in the lung digest
for Foxp3+Gata3- (A) and littermate controls (B) was determined by flow cytometry.
Foxp3+Gata3- and littermate controls were photographed at day 15 of life (C).
Foxp3+Gata3- pups and littermates were counted in each litter (D) and were weighed
daily (E). Data show mean ± SD. * p< 0.05 by student’s T test.
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Figure 5.4 Foxp3+Gata3- pups express higher levels of Tbet without an increase of IFNγ
producing cells.
2 day old Foxp3+Gata3- mice and littermate controls were infected with an LD10 dose of
the PR8 strain of influenza virus. TBLN were obtained from infected Foxp3+Gata3- mice
and littermate controls at day 13 of infection and proportion (A) and total numbers (B) of
Foxp3+ CD4+ T cells were determined by flow cytometry. Proportion of CD4+ (C) and
CD8+ (D) cells that were IFNγ+ were enumerated in lung digest of infected Foxp3+Gata3mice and littermate controls at day 13 of infection by flow cytometry. Proportion Tbet+
of Foxp3+ (E) and CD4+ (F) cells was determined for TBLN of infected Foxp3+Gata3mice and littermate controls at day 13 of infection by flow cytometry. Data show mean ±
SD for two separate experiments. KO n=3. WT n= 9. * p<0.05 by student’s T test.
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Figure 5.5 Treg specific KO of Gata3 did not reduce hemagglutinin neutralizing antibody
and increased morbidity during infection.
2 day old Foxp3+Gata3- mice and WT littermate controls were infected with an LD10 dose
of the PR8 strain of influenza virus. TBLN were obtained from infected Foxp3+Gata3mice and littermate controls at day 13 of infection and proportion (A) and total numbers
(B) of CD19+ cells were determined by flow cytometry. Hemagglutinin neutralizing
antibody titer in the serum of infected Foxp3+Gata3- mice and littermate controls was
determined at day 13 post infection by hemagglutinin inhibition assay (C). Mice were
weighed daily (D) and daily weight change was measured (E). Data show mean ± SD for
two separate experiments. KO n=3. WT n= 9. * p<0.05 compared to littermate controls at
the same timepoint by one-way ANOVA followed by Holm-Sidak post-hoc test for
pairwise comparisons.
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CHAPTER 6. OVERALL DISCUSSION
The neonatal vulnerability to infection poses a difficult challenge for potential
immunological intervention. Significant evidence and thought suggests that the globally
diminished function of the neonatal immune system is required to avoid devastating
immunopathology and ensure effective development of tolerance to innocuous antigens
(Harbeson, Francis, et al., 2018). Nevertheless, interventions can and should be made to
improve neonatal health. This usually takes the form of vaccines, and the field of
vaccinology includes an impressive list of successes for human health. There are,
however, warnings as well. Vaccinations can provoke unintended or harmful responses
as was the case with early efforts at RSV vaccination. These vaccines resulted in
significant morbidity and even mortality among treated infants (Delgado et al., 2009).
Beyond this, many vaccines function poorly in neonates, requiring older age or multiple
doses to stimulate effective protection (Robinson et al., 2019).
It has become clear that sophisticated new methods of immune manipulation and
vaccination are sometimes required to safely improve outcomes in neonates. Vaccines
often try to mimic natural infections. This follows the reasonable logic that when faced
with the complexity of a protective immune response, it may be best to allow the immune
system to operate as naturally as possible during a vaccine response for the best chance of
establishing protective immunity. This becomes problematic, however, when the natural
response to an antigen or a pathogen provides sub-optimal protection. Such is the case
with conventional attempts at HIV vaccination, and even conventional influenza
vaccination. Recent work demonstrated the feasibility of designing a vaccine that would
preferentially activate and expand a specific germ-line B cell clone that could produce
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broadly neutralizing antibody against HIV after somatic hyper-mutation and affinity
maturation (Abbott et al., 2018). These B cells are not dominant during normal viral
responses, but through novel antigen stimulation, they were able to provoke a significant
response from these subdominant cells.
I have shown in chapter 3 that neonates display an altered immunodominance
hierarchy. I have also shown in chapter 4 that the dominant PA224-233-specific cells pups
express are not protective during influenza virus infection. This is consistent with adult
studies that showed that PA224-233 vaccinated adults are not protected during influenza
infection. PA224-233 and NP366-374 are both presented by dendritic cells, but infected
respiratory epithelial cells only present NP366-374 (Chen et al., 2004a; Crowe et al., 2003).
This likely shapes the strongly NP366-374 dominant hierarchy of adult secondary infections
as it is thought that infected epithelial cells are the principal activators of memory CD8+
T cells during influenza virus infection. This agrees with what we saw in the strongly
NP366-374 dominant adult secondary infections (Figure 3.3 A).
Mice first infected as pups, however, demonstrated an onset of antigen specific
cells more characteristic of adult primary infections. It is possible that the mice first
infected as pups had no significant memory population of NP366-374-specific cells to
quickly activate during secondary infection, and the memory PA224-233 cells they did
possess were not activated by infected epithelium. The antigen specific cell expansion in
these mice may represent dendritic cell stimulation in the lymph node as if this was a
primary infection. Even without a rapid CD8+ T cell response, these mice survived a
lethal infection. It is possible that the increased protection of mice first infected as pups
is due to CD4+ T cell memory. Although some of the dominant CD4+ T cell epitopes are
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within HA, others are in NP and would probably offer protection during heterosubtypic
secondary infections (Crowe et al., 2005).
In the case of CD8+ T cell vaccination, the failure of generating protection from
PA224-233 vaccination in pups and adults suggests that simply vaccinating neonates with
antigens they can respond to naturally may not be an effective strategy for improving
outcomes. A more sophisticated manipulation is required to promote adult-like
immunodominance in neonates. I was not able to stimulate a NP366-374-specific response
in neonates with a vaccine, but I was able to detect NP366-374-specific cells in infected
mice that received adult BMDCs. Therefore, at least in the context of PR8 infection of
C57Bl/6 mice, the neonatal immunodominance hierarchy can be changed with proper
stimulation. Formulating the specifics of that stimulation and how they relate to human
infant responses will require much more work, but theories can be made based on current
knowledge.
Immunodominance of CD8+ T cells is fundamentally a product of four primary
factors. These are: the peptides that the MHC-I of a particular individual can bind for
presentation to CD8+ T cells, the efficiency of processing and presentation of potential
epitopes by APCs, the T cells that are available to respond to the presented peptides, and
the suppressive effect of dominant CD8+ T cells on T cells of another specificity (Chen et
al., 2000). These factors have been extensively dissected in adult C57Bl/6 mice infected
with PR8 influenza virus, but they are only now being understood in pups. We have
provided data that will help fill in a few holes in this body of knowledge with the hope
that by illuminating basic functions of neonatal mouse immunodominance, future efforts
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will be able to impact neonatal human immune reactions in highly specific and effective
ways to improve vaccination or acute care outcomes.
MHC haplotype is the most important factor in determining which epitopes can be
part of the immunodominance hierarchy for a particular infection in a particular
individual, as only peptides that can bind to MHC class I have any chance of interacting
with CD8+ T cells. It is also a direct outcome of the genes an individual possesses and
should not differ between an adult and a neonate of the same MHC haplotype. This is
demonstrated in our mice by the observation that pups respond to the same PA epitope
(224-233) as adults. They also respond to the same NP epitope as adults when they are
able (Figure 3.5 A). We did not test whether pups responded to different epitopes than
those that appear in the adult hierarchy, but if there were significant differences between
what peptides MHC class I was presenting in pups and adults, then we would likely not
see the same set of peptides making up the hierarchy of pups and adults within our inbred
C57Bl/6 system. Theoretically different subclasses of MHC class I could be expressed in
different levels in pups and adults, but both NP366-374 and PA224-233 are presented by
H2Db, making it unlikely that this is a driving mechanism of the altered neonatal
responses to these two epitopes. Humans, of course, have much more diverse MHC class
I and as such have diverse immunodominance hierarchies. We do not predict, however,
that the peptides presented by a particular human haplotype will differ between infants
and adults.
Acquisition, processing, and presentation of different viral peptides by antigen
presenting cells such as dendritic cells as well as infected respiratory epithelial cells may
be a central mediator of altered neonatal immunodominance in primary infections.
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Dendritic cells can acquire antigen through direct infection or phagocytosis of infected
materials (Bachmann et al., 1996; Ho et al., 2011). During adult infections, it is known
that NP366-374 is presented through direct presentation by influenza infected DCs without
requiring immunoproteosome processing, while PA224-233 requires processing in the
immunoproteosome and cross-presentation by DCs that ingest infected cellular debris
(Chen et al., 2004b). There is some debate over whether neonatal dendritic cells can
cross-present phagocytosed material effectively with human data suggesting no defect
(Gold et al., 2007), and mouse data showing that neonatal DCs are unable to crosspresent soluble antigens effectively (Kollmann et al., 2004). The strongly PA224-233dominant neonatal response suggests that neonates have APCs capable of processing
PA224-233 with the immunoproteosome and cross-presenting PA224-233 to CD8+ T cells.
The lack of an NP366-374 response, on the other hand, suggests several other possibilities
for neonatal dendritic cell function.
First, there may be a defect in direct presentation of viral peptides to MHC class I in
neonatal dendritic cells, but I have not found any published evidence of this. Second,
neonatal dendritic cells are less prevalent than adult DCs which may cause problems in
and of itself. It is possible that few DCs are directly infected early in the course of
influenza virus infection and as a result must obtain viral antigen from infected epithelial
cells. Finally, neonatal DCs may present NP366-374 in some fashion, but for some reason,
such as the poor stimulatory capacity of neonatal DCs, NP366-374-specific naïve CD8+ T
cells cannot be activated by these APCs. Adult NP366-374-specific T cells have slightly
lower affinity than PA224-233-specific cells which may require a higher threshold of
stimulation for proper activation (Cukalac et al., 2014; Luciani et al., 2013).
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It is now known that BMDCs generated by GM-CSF do not represent any natural
dendritic cell population (Helft et al., 2015). They do, however, collect and present
antigens well to T cells, especially after LPS stimulation (Boonnak et al., 2013;
Ebrahimi-Nik et al., 2018). As such, they represent a sort of activation ideal and can help
us bypass some of the limitations of neonatal immunity and examine whether those
factors played a role in the outcomes observed in infected mice. During the adoptive
transfers performed for Figures 3.4 and 3.5, the influenza virus infected BMDCs would
be able to present antigen directly to CD8+ T cells with adult levels of stimulation (Herter
et al., 2005). Transfer of these BMDCs did promote NP366-374-specific cells in pups, but
the transferred cells were enough to promote the generation of NP366-374-specific cells
with or without prior infection of the BMDCs (Figure 3.5). It is not clear whether the
uninfected BMDCs become infected once transferred to the pups. As such, I cannot
determine whether the superior activation potential of BMDCs or the access to infected
DCs is responsible for the shift in immunodominance observed in these animals. If the
infection of DCs is important, however, pre-infected BMDCs would likely offer an
advantage in the speed of the response. This is supported by the earlier onset of antigen
specific cells and improved viral clearance in animals that received infected BMDCs
(Figure 3.5).
Notably, we found a lack of response to NP366-374 loaded BMDC vaccination
(Figure 4.1 B). As I mentioned before, it may be important to consider the role of CD4+ T
cells in this process. Adult BMDCs will be able to stimulate CD4+ as well as CD8+ T cell
responses from whole virus, but not from CD8+ T cell restricted peptide epitopes. It is
well recognized that CD4+ T cell help is an important component of robust CD8+ T cell
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memory (Bedoui et al., 2016; Epstein et al., 1998), and it is possible that activated CD4+
T cells provide some essential help to NP366-374-specific reactions in neonates that allows
them to respond to live virus and BMDCs, but not peptide and BMDCs.
Differential precursor frequency of NP366-374 and PA224-233 specific CD8+ T cells is
linked to immunodominance in adults (Cukalac et al., 2014), but nothing is known about
neonatal precursors for these epitopes. Studies in RSV have suggested that neonates have
altered ratios of precursors for different epitopes within RSV compared to adults, but this
is an analysis of 2-4 cells per animal and it is difficult to assess how significant these
differences actually are (Ruckwardt et al., 2011). Ruckwardt et al. reported that the
altered precursor frequency did not predict the immunodominance hierarchy of RSV
infection in pups. Regardless, precursors for a specific epitope appear to be exceptionally
rare in neonates even by the standards of naïve T cell precursors, and this rarity may in
and of itself impact the altered hierarchy observed in pups. In fact, if the inability to
respond to NP366-374 was more absolute, it could suggest that neonates simply lack NP366374-specific

T cell precursors early in life. Studies have shown that neonates have

reduced TCR variability compared to older pups and adults (Carey et al., 2016).
However, we argue that this is not likely as we did see pups responding to NP366-374 under
certain circumstances suggesting that pups must have NP366-374- specific T cell precursors
(Figure 3.5 A).
The existence of precursors is not the only T cell intrinsic factor for determining
an immunodominance hierarchy. Studies have shown that PA224-233-specific T cells have
higher TCR binding affinity than NP366-374-specific cells (Cukalac et al., 2014; La Gruta
et al., 2004). Adult DCs can stimulate both NP366-374 and PA224-233-specific CD8+ T cells,
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but it is possible that the lower stimulatory capacity of neonatal DCs cannot reach the
activation threshold of naïve NP366-374-specific cells. This could explain why adult
BMDCs were able to stimulate NP366-374 responses in neonates. As mentioned before,
this may require CD4+ help as peptide loaded BMDCs did not stimulate an NP366-374
response. The observation that pup lung tissue can activate NP366-374-specific memory
cells is consistent with this theory as memory cells have a lower threshold of activation
than naïve cells (Kumar et al., 2011; Slifka et al., 2001). This phenomenon has been
suggested in neonatal RSV infections. T cells specific for the adult dominant epitope
have lower affinity than subdominant epitopes and pups display a reduced response to
this low affinity dominant epitope (Ruckwardt et al., 2018).
The final major determinant of CD8+ T cell immunodominance is suppression of
subdominant epitopes by dominant ones. Suppression of a dominant specificity of CD8+
T cell by a subdominant specificity is the result of competition between T cells for access
to stimulation by antigen presenting cells (Chen et al., 2000; Willis et al., 2006). We saw
that simultaneous vaccination with NP366-374 and PA224-233 in adults resulted in PA224-233
dominance (Figure 4.1 C). This is consistent with published findings that PA224-233
dominates over NP366-374 when antigen doses are similar (Cukalac et al., 2014). It is
interesting to note that when adults are vaccinated for PA224-233, it not only fails to
provide protection during a challenge infection, but the PA224-233 dominant secondary
response prevents any appreciable NP366-374 response from developing, leading to worse
outcomes (Crowe et al., 2005). The PA224-233 dominant neonatal response to primary
infection, however, does not prevent an NP366-374-specific response in later secondary
infections (Figure 3.3 A). It is possible that the poor survival and function of memory
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CD8+ T cells generated early in life (Connors et al., 2018; Smith et al., 2014) partially
alleviates the “locking in” of suboptimal CD8+ T cell specificities for subsequent
infections that has been observed with neonatal responses before (Rudd et al., 2013). It is
not clear whether this phenomenon extends to peptide vaccination as while PA224-233
vaccinated mice had a detectable NP366-374 response when challenged, we did not follow
them long enough to see if the PA224-233 vaccinated mice would develop a significant
NP366-374- specific response later in the infection. It is also possible that the two months
between primary and secondary infections in Figures 3.2 and 3.3 result in a less “locked
in” memory immunodominance hierarchy than the challenge infections two weeks after
vaccination in Figure 4.2.
The majority of published data on the NP366-374 and PA224-233 hierarchy in adult
mice suggests that NP366-374-specific cells are not dominant because they have a T cell
intrinsic advantage over PA224-233 cells, but instead they likely dominate because PA224-233
requires immunoproteasome processing to be resented, it is much easier to present NP366374

than PA224-233 both in DCs and infected target cells (Crowe et al., 2003). Although we

have not tested NP366-374 and PA224-233 presentation in neonatal tissues, these findings
suggest that differential presentation of NP366-374 and PA224-233 is less likely to be the
major driving force behind the dominant PA224-233 response in pups. Instead, I propose
that the magnitude of DC stimulation provides the crucial difference between neonate and
adult CD8+ T cell responses and that CD8+ T cells can be a promising target for neonatal
vaccination if increased DC stimulation is provided.
To conclude the discussion of immunodominance in neonatal infections, I want to
address one more question. Why would the immunodominance hierarchy in neonates
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favor an epitope that cannot generate effective CD8+ T cell responses? It is possible that
this is an adaptation by influenza virus to diminish effective CD8+ T cell immunity,
although this seems to have little effect on CD8+ T cell mediated clearance of virus
during normal adult infections. It is also possible that altered immunodominance protects
neonates from immune pathology during infection. An adult study with RSV infection
has shown that shifting the hierarchy to favor the RSV epitope pups preferentially
respond to reduces inflammation and morbidity (Ruckwardt et al., 2010). They, however
also show that mice with shifted hierarchies have no defect in viral clearance. It is not
clear if altered immunodominance is beneficial in avoiding severe immunopathology in
neonatal influenza virus infections, but our data suggests that this may not be the case.
Inducing NP366-374-specific cells with PR8 loaded BMDCs improved viral clearance
without increasing morbidity (Figure 3.5). Further study is needed to assess whether
shifted immunodominance exists in neonatal responses to other common mild early life
infections such as rhinovirus to determine if this may be an important mechanism of
pathology sparing in infants.

Manipulating Tregs is often discussed in the context of decreasing suppressive
function to bypass the immunosuppressive solid tumor environment or increasing
suppressive function to combat autoimmunity, but these cells have been fairly extensively
studied in the context of infection as well. This is less true for neonatal infections, but
some things are known. Others have shown that a reduction of Tregs in neonates that
overexpress them improves clearance of influenza virus (Jaligama et al., 2017), and we
have shown that elimination of Tregs decreases viral clearance (Oliphant et al., 2015).
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Unsurprisingly, studies have also shown that elimination of Tregs can dramatically
increase morbidity in neonatal infections (Tucker et al., 2013). These three findings
encapsulate the central factors surrounding Treg manipulation.
Manipulation of Tregs during infection must decrease suppression just enough to
improve responses without allowing intolerable levels of immune pathology, all the while
avoiding compromising the essential pro-immune function of Tregs in influenza virus
defense. Our data presents some evidence that it is possible to decrease suppressive
function of Tregs without compromising some pro-immune function, but all
manipulations we attempted still resulted in increased morbidity. In fact, neonates may
be fragile enough that a safe, therapeutic range of Treg intervention might not exist in this
population.
I will present three theories that may explain why Treg depletion is detrimental to
viral clearance. The first was proposed in adult mice and suggests that Tregs promote T
follicular helper (Tfh) cell function, and therefore antibody production, by taking up IL-2
that would otherwise inhibit the generation of Tfh cells (Leon et al., 2014). The second
suggests that without Tregs, competition between virus specific CD4+ T cells and
autoimmune CD4+ T cells prevents adequate Tfh generation and interferes with effective
immunity. Third, Tregs may perform some direct pro-immune effector function such as
production of conventional Th cytokines.
Leon et al. demonstrated that adult mice depleted of Tregs had low numbers of
influenza specific Tfhs in their lymph nodes along with diminished germinal center B
cells (Leon et al., 2014). We saw a decrease in Tfh and anti-influenza virus antibody titre
in scurfy neonates. We know from previous work that viral clearance is significantly
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diminished in scurfy pups (Oliphant et al., 2015), and although these mice were not
followed long enough to establish whether survival was possible, Treg depletion reliably
resulted in extensive morbidity and mortality during all experiments performed (data not
shown). In contrast to this, reports have suggested that Treg depletion does not change
the course of influenza disease progression in adults (Betts et al., 2011). This was a
partial depletion with anti-CD25 antibody, but depletions I performed in adult Foxp3DTR
mice, survived better than similarly depleted pups (data not shown). This is far from
conclusive, but it suggests that Treg depletion in adult mice either does not compromise
viral defense as significantly in adults as in pups, or that the increased inflammation from
Treg depletion is much more lethal in pups than adults.
Neonates have poor Tfh function (Mastelic et al., 2012) and low Tfh numbers
(Figure 5.1 A) may be especially sensitive to disruptions of this essential population. It is
not currently clear if the decreased Tfh cell population in Treg depleted animals is
responsible for the diminished antibody production scurfy pups exhibit, but decreased
antibody production is a likely cause of diminished viral clearance. B cell deficient mice
are essentially unable to clear highly pathogenic influenza strains like PR8
(Mozdzanowska et al., 1997; Mozdzanowska et al., 2000).
Polyclonal autoimmunity is characteristic of Treg deficient animals (Kim et al.,
2007). Scurfy pups and Treg depleted mice develop lymphadenopathy from massive
autoimmune activation of lymphocytes. Somewhat paradoxically, during influenza
infection, Treg depleted animals develop smaller lymph nodes than undepleted infected
animals. This diminished size could be related to the poor development of Tfh cells as I
mentioned before, but it could also result from the extensive exodus of activated
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autoimmune and virus-specific lymphocytes to the infected lung tissue. We showed that
Treg depleted pups had an increase in CD4+ T cells and IFNγ+ CD4+ T cells in the lungs
during infection, possibly indicating that this mass migration has occurred (Figure 5.1 G,
H).
Previous work has suggested that influenza specific CD4+ T cell populations in
the lymph node are split between Tfh and non-Tfh cells. These populations compete in
the lymph node and extensive non-Tfh CD4+ populations can suppress effective Tfh
responses (Olson et al., 2016). During Treg depletion in infected animals, the significant
polyclonal expansion of T cell populations may interfere with effective anti-influenza
responses as well as anti-influenza Tfh generation. It is not clear if autoreactive cells are
able to compete with influenza virus-specific CD4+ T cells in the germinal center, but if
competition reduces Tfh generation or results in non-influenza specific Tfh generation,
this could have a serious impact on effective anti-influenza virus antibody production, as
it has been clearly demonstrated that Tfh viral specificity is required for effective antiviral B cell help (Deenick et al., 2010; Qi et al., 2014).
Tregs have well recognized proinflamatory functions under certain circumstances,
although this is usually appreciated in the setting of autoimmune disease. It is possible
that Tregs are required to perform a Th-like function in neonates, although they do have
conventional CD4+ T cells that respond during infections. We do not have any evidence
of Tregs producing conventional effector cytokines in neonatal influenza virus infections,
but it may be worth examining in the future. We did, however, assess expression of the
conventional CD4+ T cell associated transcription factors Tbet and Gata3 in neonatal
Tregs.
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While several studies suggest that Gata3 plays a role in Treg function, the scope
of that involvement is poorly defined. We showed that a high proportion of neonatal
Tregs express Gata3 (Figure 5.2 B), but it is unclear if this is evidence of some age
specific role of Gata3 in Treg function or simply a consequence of Tregs existing in a
neonatal environment. IL-4 stimulation is known to upregulate Gata3 in Tregs
(Noval Rivas et al., 2015), so it is possible that Gata3 expression in neonatal Tregs is
related to the Th2 bias and IL-4 production neonatal mice experience during many
infections (Adkins et al., 1992; Coutinho et al., 1994). Uninfected pups also have
elevated proportions of Gata3+ Tregs, so this may not be a key mechanism. Asthmatic
patients have a Th2 biased environment, and these individuals also have high proportions
of Gata3 expressing Tregs (Chen, Hou, et al., 2018). Once again it is not clear if this is
the product of T helper cells biased towards a Th2 response in an atopic individual or the
direct result of the IL-4.
Several studies suggest that the primary role of Gata3 in Tregs is to support Foxp3
expression and therefore maintain suppressive function (Abdel Aziz et al., 2018;
Wohlfert et al., 2011). Other studies suggest that Tregs can express transcription factors
like Gata3 and Tbet to dedifferentiate into poorly suppressive cells that produce
proinflammatory cytokines (Xu, Yang, et al., 2018). This raises the question of whether
Gata3+ Tregs in neonates are transitioning to non-suppressive cells or if the Gata3
expression is part of their suppressive function. Treg populations remain high during
infection in neonates and other studies have suggested that CD4+ T cells in neonates are
biased towards becoming Tregs after stimulation rather than the reverse (Wang et al.,
2010). Additionally, Leon et al. demonstrated that Tfhs in adult mice did not
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differentiate from Treg precursors (Leon et al., 2014). We did not demonstrate that dedifferentiation of Foxp3+ Tregs to Foxp3- conventional T cells is not occurring in infected
pups, but there is also no evidence of this occurring at this time.
We generated mice with Treg specific loss of Gata3 to examine the role this
transcription factor might be playing in neonatal infections. We did not see a significant
decrease in B cells or influenza virus neutralizing antibody production in Foxp3+ Gata3pups, suggesting that Gata3 is not responsible for the pro-antibody function of Tregs.
Instead, Foxp3+Gata3- mice exhibited a phenotype consistent with diminished but not
absent suppressive function both before and during infection.
There is debate about whether loss of Gata3 in Tregs results in a significant defect
in Treg suppressive function. Some have reported no effect (Yu et al., 2015) and others
have suggested that these animals develop autoimmunity several months into life
(Wohlfert et al., 2011; Xu, Yang, et al., 2018). The small size of our Foxp3+Gata3- pups
and their reduced representation in litters suggests that they are less healthy than Gata3+
littermates. Additionally, during infection, Foxp3+Gata3- pups have an increase in Tbet
expression and IFNγ producing CD4+ T cells in the lung (Figure 5.4 E). This is similar to
the increase in cell number and Th1 function that scurfy pups exhibit, and as such
possibly indicates a decrease in suppressive function (Oliphant et al., 2015). The increase
in IFNγ expression correlates with increased morbidity in Foxp3+Gata3- pups (Figure 5.5
E). Foxp3+Gata3- pups did not experience the high lethality of a full Treg depletion, but
they do exhibit some of the increased morbidity associated with other studies of Treg
depletion in infection (Lee et al., 2010; Suvas et al., 2004; Tucker et al., 2013).
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I do not think that reducing Treg function is currently a worthwhile goal in the
process of improving neonatal influenza virus vaccination or infection. Neonates are too
intolerant of increased inflammation and the adaptive immune response to influenza virus
is too specific to support reducing Treg function in this age group.

6.1

Limitations and further directions
While peptide vaccination is undoubtedly useful for personalized immunotherapy

for cancer, it is likely not an ideal strategy for generating antiviral responses in a broad
population. The immunodominant epitopes of PR8 infection in C57Bl/6 mice are known
and predicable, but human infections with a diverse array of influenza virus strains and a
broad range of HLA haplotypes are not as consistent. While human CD8+ T cells
responses are often reliably stimulated by a few viral subunits, peptides are too specific.
As such, we do not know if human infants experience altered immunodominance during
influenza virus infection, nor what form such a shift would take. The altered
immunodominance of neonatal mice to RSV infection suggests that this is not a
phenomenon of a single infection, but we do not have confirmation that this is a human
phenomenon as well. In a practical sense, any vaccine tested for use in humans will be
tested in neonates before being used extensively in this population, and this will ascertain
the response to any antigens used in a particular vaccine. Further work understanding the
determinants of neonatal immunodominance in mice will hopefully help resolve whatever
difficulties arise in the use of subunit T cell vaccines in human neonates.
I have now outlined many questions regarding dendritic cell function and I believe
understanding this cell population better lies at the heart of any efforts to improve
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neonatal T cell responses. While others have pointed to the immaturity of the T cell
receptor repertoire (Carey et al., 2016), we have shown that BMDCs could alter the
activation of these immature cells. Beyond this, manipulating dendritic cells is likely a
much more feasible and safe goal than trying to alter the TCR repertoire of infants. I will
propose what I believe are the most immediate goals of future work regarding
understanding neonatal immunodominance during influenza virus infection.
First, we must determine whether neonatal dendritic cells can present both NP366-374
and PA224-233 during influenza virus infection. If they cannot, we should investigate
whether direct presentation and cross-presentation mechanisms are intact in neonatal
dendritic cells. This may involve examining components of the peptide processing
pathways and expression of MHC class I. Also, while work has characterized defects in
the stimulatory capacity of neonatal DCs, we will need to ascertain whether this poor
stimulation prevents adequate activation of NP366-374 specific cells.
Second, we need to find a way to safely mature neonatal dendritic cells in vivo.
While it is known that administering LPS (Malloy et al., 2017), GM-CSF (Qureshi et al.,
2005) or Flt3 ligand (Remot et al., 2016) can improve neonatal DC maturity, perhaps the
most crucial task will be determining if this maturation can be done in a specific and
limited manner to avoid excess activation. While vaccination with autologous GM-CSF
derived dendritic cells is performed for cancer immunotherapy, it is hardly a desirable
procedure for routine vaccination. Conventional adjuvants are needed.
Third, while we showed evidence of the role immunodominance plays in neonatal
CD8+ T cell responses to influenza virus, we did very little to characterize the CD4+ T
cell immunodominance hierarchy and the role of CD4+ T cells in subunit vaccination.
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CD4+ T cell immunodominance is challenging to study, as the reagents are less
developed and the hierarchy is typically much broader than CD8+ T cells hierarchy
(Crowe et al., 2006), but effective use of subunit vaccines in neonates will require
understanding whether the neonatal CD4+ T cell hierarchy is shifted as well and whether
the different T cell specificities in that hierarchy are able to provide adequate protection.
As CD4+ and CD8+ T cells do not share peptide epitopes, this relates more to subunit
vaccination than peptide vaccination, but similar principles apply. Our data suggest that
CD4+ T cell memory may be playing an important role in T cell memory established as a
pup as mice first infected as pups were protected from lethal heterosubtypic influenza
virus infection (Figure 3.2 A) despite not displaying an early onset of NP366-374-specific
cells (Figure 3.3 A).
To revisit a significant concern with the methodology, I spoke in chapter 3 about
the possibility of tetramers underestimating antigen specific populations (Rius et al.,
2018). This is an important concern, especially as I suggested that the lower affinity of
NP366-374 cells may be related to their lack of expansion in neonates. I believe the data
obtained here is accurate for two reasons. First, we detected NP366-374-specific cells by
tetramer both in the few pups that naturally respond to NP366-374 and in the pups that
received adult BMDCs, suggesting that tetramers can detect NP366-374-specific cells
produced by pups. Second, pups repeatedly demonstrated significantly lower IFNγ
production when stimulated with NP366-374 and BMDCs than adults stimulated with
NP366-374 and BMDCs or pups stimulated with PA224-233 and BMDCs. BMDC stimulation
is more sensitive than tetramers and should have detected a significant NP366-374-specific
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population if it existed. ELISPOT is even more specific and sensitive and would give the
most certain answer as to whether this population is really absent.

Our data on the role of Tregs in influenza infection is particularly limited due to
the high mortality rate of Treg depleted mice. Additionally, the total loss of Tregs results
in extremely atypical immunity that makes it difficult to isolate single causes for a given
phenomenon. In part because of these difficulties, many questions remain about the role
of Tregs in neonatal influenza virus infections. We showed a decrease in Tfh cells after
Treg depletion, but it is not clear how functional the remaining Tfh cells are. IL-21
production and CD40 expression could demonstrate these cells’ capacity to help B cells
during infection.
Neonates have disorganized germinal center morphology under normal
circumstances (Munguía-Fuentes et al., 2017), but it would be useful to know if Treg
depletion disrupts these structures further. Microscopy of Treg depleted TBLNs would
help address this question. If IL-2 inhibits Tfh generation in Treg depleted adults, we
should examine lymph nodes of Treg depleted pups to see if IL-2 levels are increased.
Additionally, I did little to characterize B cell function in the lymph node.
Examining class switching would help illuminate whether B cells are receiving adequate
help. Finally, more sensitive anti-influenza antibody screening in the lavage by ELISA
could help ascertain whether scurfy pups lack an antibody response or if it is just
diminished. Hemagglutination inhibition assays are not as sensitive.
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The full role of Gata3 in Tregs remains unclear. The increased Tbet expression in
KO pups could suggest that KO Tregs are less suppressive than WT cells, although an in
vitro suppressive assay is needed to fully demonstrate this. Loss of Gata3 does not
reduce Treg ability to suppress ulcerative colitis (Yu et al., 2015), but the gross
phenotypic changes we observed in KO mice suggests that there may be more subtle
defects, especially in pups (Figure 5.3). While the increase in Tbet expression seems
consistent, more trials are needed to determine whether there is a change in antibody
production. Future studies should also assess the function of the increased Tfh
population in Foxp3+Gata3- mice and determine whether these cells are virus specific.
As with Treg depletion studies, low sample size limits the conclusions that can be
drawn from the Foxp3+Gata3- mice. There were not enough pups to examine uninfected
Foxp3+Gata3- mice, but assessing the immune response of these animals is essential to
fully understand the effect of infection on these dysregulated neonates.

6.2

Summary
We showed that immunodominance is altered in neonatal pups and that the

differences in the hierarchy have potentially serious consequences for CD8+ T cell
vaccination in neonates. Our data suggests that responses to adult-dominant epitopes can
be generated in neonates with proper stimulation by dendritic cells. Additionally, we
showed that Tregs likely have important suppressive and anti-viral roles in influenza
infection by decreasing Th1 responses and supporting antibody generation respectively. I
propose that efforts to improve neonatal immune T cell reactions should focus on altering
dendritic cell function without tampering with Treg suppression. Overall, it appears that
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although neonatal immunity is different from adult immunity, at least some of these
differences are not absolute and can be altered by future therapies.
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LIST OF ABBREVIATIONS
A/HKx31

HKx31

A/Puerto Rico8/1934 H1N1

PR8

Acid polymerase (amino acids 224-233)

PA224-233

Antigen presenting cell

APC

B-cell lymphoma 6 protein

BCL-6

Bone marrow-derived dendritic cells

BMDCs

Bovine serum albumin

BSA

Bronchial alveolar lavage

BAL

CD103+ Dendritic cell

cDC1

CD11b+ Dendritic cell

cDC2

Chicken red blood cell

CRBC

CpG oligodeoxynucleotides

CpG

Diphtheria toxin receptor

DTR

Ethylenediaminetetraacetic acid

EDTA\

Fetal Calf Serum

FCS

FMS-related tyrosine kinase 3 ligand

Flt3L

Forkhead box p3

Foxp3

GATA binding protein 3

Gata3

Granulocyte-Monocyte Colony Stimulating Factor GM-CSF
Hank’s Buffered Salt Solution

HBSS

Hemagglutinin

HA

Hemagglutinin Inhibition Assay

HAI

Hemagglutinin Inhibition Unit

HAU

Herpes simplex virus

HSV

Human rhinovirus

HRV

Immunoglobulin

Ig

Induced bronchial associated lymph tissue

iBALT

Interleukin

IL
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Intranasal

i.n.

Intraperitoneal

i.p.

Lethal dose in 10% of mice

LD10

Lipopolysaccharide

LPS

Major histocompatibility complex

MHC

Matrix protein 1

M1

Matrix protein 2

M2

Neuraminidase

NA

Nonstructural protein 1

NS1

Nonstructural protein 2

NEP

Nucleoprotein (amino acids 366-374)

NP366-374

Pathogen associated molecular patterns

PAMPs

Pattern recognition receptors

PRRs

Plasmacytoid dendritic cell

pDC

Phorbol 12-myristate 13-acetate

PMA

Polymerase basic protein 1 frame 2

PB1-F2

Polymerase basic protein 1

PB1

Polymerase basic protein 2

PB2

Protein blocking agent

PMA

RAR-related orphan receptor gamma

RORγ

Respiratory syncytial virus

RSV

Ribonucleoprotein particles

RNPs

Roswell Park Memorial Institute

RPMI

T cell receptor

TCR

T follicular helper cell

Tfh

T helper

Th

T regulatory cells

Treg

T-box transcription factor TBX21

Tbet

Toll-like receptors

TLR

Tracheal-bronchial lymph node

TBLN
139

Transforming growth factor beta

TGFβ

Tumor Necrosis Factor alpha

TNFα

Type I interferon alpha

IFNα

Type II interferon gamma

IFNγ
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